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WILLIAM JOHN BERG LIND. The Role of Brain-Derived Growth Factor in the
Prefrontal Cortex on Relapse to Cocaine Seeking. (U nder the direction of
JACQUELINE F. MCGINTY)
Glutamatergic pyramidal cells arising from the prefrontal cortex (PFC) are critical
mediators of reinstatement to cocaine-seeking. A potent modulator of PFC activity is
brain derived neurotrophic factor (BDNF), a molecule that has been implicated in the
regulation of glutamatergic neurotransmission. In this study, the role of BDNF in the PFC
was investigated in an animal model of cocaine addiction. First, a cocaine-induced
decrease in BDNF mRNA within the PFC was documented following 22 h of abstinence,
followed by an increase in BDNF protein expression within the PFC following 21 d of
extinction training. Second, an intra-PFC infusion ofBDNF attenuated relapse to cocaine
seeking following drug abstinence and reinstatement of cocaine seeking after extinction
training.

Furthermore, the intra-PFC infusion of BDNF prevented cocaine-induced

decreases in phospho-ERK expression in the nucleus accumbens (NAc), implicating the
PFC-NAc pathway in BDNF's suppression of cocaine seeking.

Disturbance in this

pathway underlies the decrease in extracellular glutamate levels in the NAc during
withdrawal from chronic cocaine and an increase in glutamate levels after cocaineprimed reinstatement of drug seeking.BDNF prevented the decrease in basal
extracellular glutamate levels following cocaine self administration and the increase in
cocaine prime-induced glutamate levels in the NAc. These data indicate that cocaineinduced neuroadaptations within the PFC-NAc pathway are normalized by intra-PFC
BDNF treatment. Considering that 1) these effects are long-lasting and are the result of a
single dose of BDNF and 2) the infusion is only efficacious when administered shortly
after the end of cocaine self-administration, the possible therapeutic implications are

VI

significant and serve as the impetus for future investigation into the mechanisms involved
in the ability of intra-PFC BDNF infusions to suppress cocaine seeking behavior.
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CHAPTERl
INTRODUCTION

The enduring effects of cocaine abuse have had a devastating effect on our society.
Since cocaine's introduction in the late nineteenth century, countless individuals have
fallen victim to its spell, seduced by the paradox of immense pleasure ultimately causing
immense suffering. The long-term. behavioral effects of chronic cocaine abuse are
characterized by endless cycles of cocaine use, abstinence, and then relapse to cocaine
seeking.

These interminable cycles cause catastrophic long-term changes in specific

reward-associated brain circuitry. Furthermore, these long-term neuroadaptations only
serve to perpetuate the cycle of addiction and lead to a deadly spiral from which there is
little chance of escape. For this reason, researchers have for decades sought to determine
what neuronal targets are critical in the long-term cocaine-induced neuroadaptations that
underlie the development of addiction. As a result, there is much greater understanding
of how the natural reward circuitry is hijacked and forced to be subservient to the pursuit
of cocaine alone.

These servile diseased brain regions slowly silence the beautiful

symphony that is the human mind and trade it for a singular, shrieking drive that is the
addicted brain.

This horror does not happen overnight. Therefore, substance abuse

research has sought to delineate the chronic neuroadaptations induced by cocaine that
ultimately playa major role in driving relapse and addiction.

REVIEW OF LITERATURE

Adaptations Associated with Addiction and Relapse

The behavioral adaptations that characterize cocaine addiction are caused by
drug-induced, long-term neuronal adaptations that alter neuronal circuits and substrates
(Koob et aI., 1997a; Wang and McGinty, 1997; White and Kalivas, 2001). Alterations in
gene and protein expression are likely a significant component of the adaptations that
lead to addictive behaviors characterized by craving and relapse (Torres and Horowitz;
Nestler, 1997; Shalev et ai., 2003).
extensively using rodent models.

Relapse to cocaine seeking has been studied

These studies have utilized re-exposure to drug-

associated contexts, discrete conditioned stimuli, stress, and cocaine itself to elicit
reinstatement to cocaine-seeking behavior in these animal models (Gerber and Stretch,
1975; de Wit and Stewart, 1981; Allerweireldt et aI., 2001; Crombag et aI., 2002; Kalivas
and McFarland, 2003; See et aI., 2005). These studies, along with many others, have
served to identify the brain areas that are altered by cocaine and are implicated in the
reinstatement of drug-seeking behavior. These structures, which are naturally associated
with reward are collectively called the motive circuit, and include the prefrontal cortex
(PFC) and its downstream target, the nucleus accumbens (NAc). Both of these structures
receive dopamine (DA) innervations from the ventral tegmental area (VTA) via the
mesocorticolimbic DA ("reward") pathway.

Many cocaine-induced neuroadaptations

that are thought to drive reinstatement of cocaine-seeking behavior are manifested by
alterations in the plasticity of the PFC-NAc pathway. These include, but are not limited
to, alterations in the electrophysiological profile of glutamatergic pyramidal neurons
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arising from the PFC (Trantham et ai., 2002; Sun and Rebec, 2006) as well as changes in
the extracellular levels of glutamate within the NAc (Pierce et aI., 1996; McFarland et aI.,
2003). Alterations within the motive circuit may induce changes in the in excitatory
neurotransmission and associated intracellular signaling of medium spiny neurons within
the NAc (Xi et aI., 2002; Baker et aI., 2003). One molecule that has been implicated in
driving changes in plasticity and is expressed within this pathway is brain derived
neurotrophic factor (BDNF; Xiong, 2002).

BDNF is a secreted neurotrophin that is

associated with modulating plasticity (McAllister et aI., 1995; McAllister et aI., 1996).
Furthermore, cortical pyramidal neurons arising from the PFC are the predominant source
of BDNF within the NAc (Altar et aI., 1997). Figure 1-1 illustrates the expression and
transport of BDNF within the mesocorticolimbic "reward" pathway where it signals
through the tyrosine kinase B (TrkB) receptor.
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FIGURE 1-1. BDNF expression within the meso-corticolimbic pathway. BDNF is
expressed in glutamatergic pyramidal neurons arising from the PFC as well as
dopaminergic neurons arising from the VT A, both of which synapse on GABAaergic
medium spiny neurons within the NAc. Furthermore, BDNF itself is transported
anterogradely to the striatum where it binds to TrkB receptors on medium spiny neurons
(Altar et aI. , 1997; Freeman et aI. , 2003). Labeling studies have demonstrated that a
majority of BDNF expression within the NAc arises from the PFC, not the VT A.

BDNF Expression is Associated with Changes in Neuronal Activity

BDNF expression and activity are extensively associated with synaptic plasticity
and ultimately induce changes in receptor-mediated intracellular signaling and
4

transcription factor activity (Lu, 2003; Patapoutian and Reichart, 2001). BDNF mRNA
and protein expression is induced by several different factors that induce neuronal
activity (Shieh and Ghosh, 1999; Lu, 2003). These include cellular mechanisms, such as
LTP-inducing tetanic stimulation (Morimoto et aI., 1998), or more global mechanisms
such as physical activity and enriched environments (Russo-Neustadt et aI., 1999; Young
et aI., 1999). BDNF mRNA expression is induced via CREB activation in a calciumdependent manner (Shieh et ai., 1998). Following transcription, BDNF mRNA can be
trafficked to the dendrites for translation and preferentially targets dendrites of active
synapses via unknown mechanisms (Steward and Schuman, 2001; Tongiorgi et ai., 1997).
Release of BDNF via synapsin-associated mechanisms and subsequent TrkB receptor
activation are associated with increased glutamatergic activity (Hartmann et aI., 2001.;
Jovanovic et aI., 2000; Balkowiec and Katz, 2002). Furthermore, BDNF promotes both
early and late-phase long-term potentiation (L TP) and increases dendritic spine formation
(Bramham et aI., 1996). This may be due the fact that BDNF promotes dendritic protein
synthesis (Kang and Schuman, 1996). Specifically, BDNF regulates spine formation at
the dendritic level by inhibiting miR-134, a micro-RNA which itself inhibits the
translation of Limk 1, a protein kinase that regulates spine formation by regulating actin
filament activity (Schratt et ai., 2006).
Taken together, this evidence suggests that alterations in BDNF protein levels
may serve as an indicator of global changes in local activity. However, alterations in
BDNF tissue levels cannot be interpreted unambiguously without also examining
downstream BDNFITrkB signaling. Such supporting evidence is necessary in order to
determine whether BDNF is being released and impacting its targets or is being
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sequestered pre-synaptically and is quiescent. Molecular evidence of BDNF activity
includes examining the cell surface localization of the TrkB receptor as well as
downstream evidence of increased TrkB signaling via protein phosphorylation.

BDNF-induced Activation of TrkB Receptors Induces Activation of Intracellular
Signaling Cascades via Phosphorylation
Changes in plasticity or synaptic efficacy occur via a number of BDNF activitydependent mechanisms, all of which depend on the interaction of BDNF with the TrkB
receptor. Initially, BDNF binding to the TrkB receptor can rapidly induce release of
intracellular calcium, like a fast-acting neurotransmitter (Rose et aI., 2004). Upon Trk
receptor activation, phosphorylation-dependent internalization of the receptor-ligand
complex occurs and is trafficked within the intracellular space via signaling endosomes
(Grimes et aI., 1996; Watson et aI., 1999). Therefore, BDNF binding reduces the cell
surface expression of TrkB receptors which are replaced by intracellular stores of TrkB
receptors that are trafficked to the cell surface in an activity dependent, but not liganddependent, manner (Meyer-Franke et aI., 1998; Du et aI., 2000). Following binding, the
BDNF/TrkB dimer complex is auto-phosphorylated and can exert its effects within the

post-synaptic neuron by activating key signaling pathways. These pathways include the
extracellular-regulated MAP kinase (ERK MAPK) cascade, phosphatidylinositol 3'kinase (PI3-K), and phospholipase Cy (PLCy) (Berhow et aI., 1996; Patapoutian and
Reichardt, 2001). Through these signaling pathways, BDNFITrkB activation leads to
increases in the phosphorylation state of transcription factors, like CREB and Elk-1,
similar to effects observed following psychostimulants and NMDA receptor stimulation
in cortical and striatal neurons (Arthur et aI., 2004; Finkbeiner et aI., 1997; Hardingham
6

et ai., 1999; Simpson et aI., 1995; Valjent et aI., 2000; Shi and McGinty, 2007). Activity
ofPI3-K and ERK modulates BDNF-induced dopamine release and GLURI expression
(Xiong, 2002; Goggi et ai., 2004). PI3-K activity also is involved in the ability of BDNF
to induce LTP within hippocampal neurons and reinforces the role of PI3-K in
modulating BDNF-induced long-term neuroadaptations (Gottschalk et ai., 1999). Most
studies of the PI3-K pathway have evaluated the phosphorylation state of AKT, a target
of PI3-K that is induced by TrkB receptor activity (Zhu et aI., 2002). Together, this
evidence provides a strong correlation between BDNF mRNA increases, TrkB receptor
activation, and the activation of ERK and PI3-kinase during neuronal activity.

BDNF-associated Intracellular Signaling Pathways Are Altered by Cocaine
The ERK MAPK pathway regulates the post-synaptic response to glutamate and
dopamine afferents in the striatum, which has implications for long-term cocaine-induced
neuroadaptations. Striatal ERK signaling has been implicated in the development of
behavioral sensitization and the rewarding efficacy of cocaine as well as in the regulation
of cocaine-induced activation of transcription factors (Valjent et aI., 2000; Valjent et ai.,
2004; Valjent et aI., 2005). Furthermore, multiple intra-VTA infusions of BDNF
decreased total ERK immunoreactivity without affecting ERK activity; however, these
studies were performed prior to the availability of phospho-specific antisera (Berhow et
ai., 1996). More recently, it was found that ERK, and not PKA, activation mediates
cocaine-induced CREB phosphorylation in the NAc of rats following repeated, passive
administration of sensitizing doses of cocaine (Mattson et ai., 2005). Additionally, the
MEK inhibitor U0126 blocked the enhancement of reinstatement induced by a single
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BDNF infusion into the VTA (Lu et aI., 2004), implicating the ERK MAPK signaling
pathway in BDNF's facilitory effects on cocaine seeking. The role of PI3-K and PLC-y
activation with respect to BDNF's facilitory effects on cocaine-induced neuroadaptations is less well studied. However, it is known that blockade of PI3K and MAPK
activity prevents BDNF mediated fear conditioning in the amygdala (Ou and Gean, 2006).
Furthermore, inhibition of PI3-K decreases the expression of cocaine-induced behavioral
sensitization (Izzo et aI., 2002). Also, acute cocaine administration induced phosphoPLCy expression within the NAc and this effect was abolished by prior infusion of antiBDNF into NAc (Graham et aI., 2007). Thus, BDNF can modulate cocaine-induced
effects via all three BDNF-associated intracellular signaling cascades.

BDNF Expression Is Altered by Chronic Cocaine Self-administration

BDNF is induced following extended periods of abstinence from cocaine selfadministration and BDNF administration regulates the reinstatement and reinforcing
effects of chronic exposure to cocaine (Grimm et aI., 2003; Lu et aI., 2004; Graham et aI.,
2007). BDNF mRNA in the mPFC is transiently induced for 2-4 h following acute
cocaine administration (Le FoIl et aI., 2005). This transient induction of BDNF mRNA
within the PFC may lay the foundation for more long-term neuroadaptations within the
PFC following chronic exposure to cocaine.

For example, 22 hr following chronic

cocaine self-administration, there is a decrease in BDNF mRNA within the mPFC
(Berglind et aI., 2007) that is followed by an increase in BDNF mRNA in the mPFC after
one week of abstinence. In addition to changes in BDNF mRNA levels within the PFC
following chronic cocaine, there are also changes in BDNF protein expression.
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For

example, BDNF protein expression is increased in the VTA, N Ac, and amygdala of rats
following 30 and 90 days of withdrawal from cocaine self-administration (Grimm et aI.,
2003).

BDNF Modulates Cocaine-induced Behavior
In addition to the effects of chronic cocaine on endogenous BDNF, exogenous
BDNF can alter cocaine-induced biochemical and behavioral changes when administered
directly into selected mesolimbic areas. Specifically, BDNF infusions into the VTA and
NAc enhanced cocaine-induced behavioral sensitization (Horger et aI., 1999). BDNF
within the VTA increased cue-induced reinstatement of cocaine seeking, a long-term
effect that lasts for up to 30 days of cocaine abstinence (Lu et aI., 2004). Additionally,
repeated high doses of intra-NAc BNDF increased cocaine self-administration and
reinstatement of cocaine seeking (Graham et aI., 2007). In contrast, injection of antiBDNF directly into the NAc attenuated cocaine-induced reinstatement when it was
infused repeatedly during chronic cocaine self-administration, and an inducible BDNF
knock-down in the NAc decreased cocaine self-administration (Graham et aI., 2007).
Collectively, these studies have implicated VTA and NAc BDNF activity in the longterm enhancement of cocaine-induced behavior.

Although the mechanisms of this

enhancement have not been investigated, it is likely that enhancement of the VTA-NAcVTA circuit is involved, considering the important role of dopamine receptor activation
in reinstatement of cocaine-seeking behavior (Bachtell et aI., 2005).

The PFC-NAc Glutamatergic Pathway is 'Critical to Cocaine-induced Reinstatement
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Glutamatergic pyramidal cells in the PFC are critical mediators of reinstatement
to cocaine-seeking. In rats whose cocaine seeking behavior has been extinguished,
inactivation of the dPFC blocks cocaine-induced and context-induced reinstatement
(McFarland and Kalivas, 2001; Fuchs et aI., 2005). Cocaine-induced disturbance of the
PFC-NAc glutamatergic pathway is implicated by studies that demonstrated a decrease in
extracellular glutamate levels in the NAc during withdrawal from chronic cocaine
contrasted by an increase in glutamate levels after a cocaine injection (Pierce et aI., 1996;
McFarland et aI., 2003) and alterations in glutamatergic receptors in the NAc (Xi et aI.,
2002; Tang et aI., 2004).

Intra-NAc manipulation of AMPA receptor agonists and

antagonists either exacerbate or block cocaine-induced reinstatement, respectively
(Cornish and Kalivas, 2001a; Cornish et aI., 1999). The combination of lowered basal
levels and cocaine prime-induced spiking of glutamate in the NAc in rats with a cocaine
self administration history characterizes a pathway that is hypoactive in the absence of
stimuli and hyper-responsive to cocaine-related stimuli. Interestingly, corroborating
evidence of this phenomenon has been demonstrated by electrophysiological studies
within the PFC (Sun and Rebec, 2006). Their data clearly demonstrate that the basal
activity of pyramidal neurons within the PFC is depressed after chronic cocaine whereas
burst firing is increased after re-exposure to cocaine. This pattern parallels the changes
observed in extracellular glutamate within the NAc, and altogether, suggest that
presynaptic changes in pyramidal cell profiles within the PFC drive cocaine-induced
alterations in the PFC-NAc pathway. However, a pivotal study by Baker and colleagues
(2003) clearly demonstrates that cocaine alters the characteristics of the cystine/glutamate
exchanger (xCT) located on glial cells and, consequently, the dynamics of glutamate re-
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uptake within the NAc.

Furthermore, normalization of xCT kinetics is sufficient to

prevent the decrease in basal glutamate and cocaine-prime induced glutamate spiking, as
well as reinstatement behavior (Baker et aI., 2003). This finding has been reinforced to
demonstrate the critical role that xCT plays in regulation of basal extracellular glutamate
levels and cocaine-induced neuroadaptations within the NAc-PFC pathway (Melendez et
ai., 2005; Moran et ai., 2005).
Therefore, there is substantial evidence to support both a PFC (pre-synaptic) and
NAc (post-synaptic) based mechanism for the long-term neuroadaptations induced by
cocaine within the PFC-NAc pathway.

Furthermore, within the context of cocaine-

induced disturbances in this pathway, the role of BDNF must be considered. BDNF
plays a critical role in maintaining homeostatic balance _within local cortical circuits that
implicates its involvement in both presynaptic and postsynaptic regulation (Rutherford et
ai., 1998). First, there is evidence that BDNF directly induces glutamate release from presynaptic stores by indirectly activating vesicular trafficking machinery (Jovanovic et ai.,
2000). Moreover BDNF exerts control on postsynaptic regulation of GluRs and ion
channels (Rose et aI., 2004).

Finally, delivery of exogenous BDNF into the NAc

enhances reinstatement behavior as well as intracellular signaling (Graham et ai., 2007).
However, few studies have investigated the role ofBDNF within the PFC-NAc pathway,
and until this dissertation research, none had investigated the role of BDNF in the PFC
following cocaine self administration.

11

Purpose of the Study

The critical importance of the PFC-NAc pathway in reinstatement to cocaine
seeking, the prominence of BDNF in this pathway, and its role in neuroplasticity,
together served as the impetus to examine the role of exogenous BDNF within the. PFC
on reinstatement to cocaine seeking. Therefore, the purpose of this research was to
investigate (1) the effects of cocaine self administration on BDNF mRNA and protein
expression (Callahan et aI., 1997), (2) the effects of exogenous BDNF infused into the
PFC on relapse to cocaine-seeking behavior and associated molecular alterations within
the NAc and (3) the effects of intra-PFC BDNF infusions on basal levels and cocaineprime-induced levels of glutamate in the NAc in rats with a history of cocaine self
administration.

Specific Aims
Specific Aim 1. Twenty-two h or 21 d after the end of cocaine self-administration'

or after a cocaine prime, evaluate the levels of BNDF mRNA and protein expression in
the NAc and PFC.

Specific Aim 2. Evaluate the effect of a single bilateral intra-PFC BDNF micro-

infusion on cue and cocaine-induced relapse to drug-seeking after the end of cocaine selfadministration.
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Specific Aim 3.

Evaluate the effects of a single bilateral intra-PFC BDNF

infusion after the end of cocaine self-administration on cocaine-induced changes in the
expression of phosphorylated ERK in the NAc.

Specific Aim 4: Evaluate the effect of a single bilateral intra-PFC BDNF microinfusion on basal and cocaine-induced levels of extracellular glutamate within the NAc
following extinction.
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CHAPTER 2

SUB-CHRONIC COCAINE SELF-ADMINISTRATION ALTERS BDNF MRNA
AND PROTEIN EXPRESSION IN THE PFC AND NAC

Introduction
Behavioral adaptations that characterize cocaine addiction are thought to be
caused by drug-induced, long-term neuronal adaptations that alter neuronal circuits and
substrates (Koob et aI., 1997; White and Kalivas, 1998; Wang and McGinty, 1999).
Alterations in gene expression and subsequent protein synthesis are likely a significant
component of these adaptations that lead to addictive behaviors such as craving and
relapse to drug seeking (Nestler, 1997; Torres and Horowitz, 1999; Shalev et aI., 2002).
Notably, gene expression changes seem to be integral to the development of behavioral
sensitization (Sorg and Ulibarri, 1995; Bibb et aI., 200 1). Cocaine administration also
alters the expression of genes associated with key neuronal signaling pathways including
kinases, phosphatases and transcription factors (Kelz et aI., 1999; Bibb et aI., 2001;
Yuferov et aI., 2003). These pathways are integral to the regulation of plasticity and
establishing connections between transcription and translation events. Cocaine
administration disrupts these signaling pathways, causing alterations in downstream gene
expression. A key signaling molecule closely associated with plasticity and regulation of
gene expression is BDNF.

BDNF expression and activity is associated with neuronal activity and synaptic
plasticity (Patapoutian and Reichart, 2001). Specifically, studies within the hippocampus
have demonstrated that long-term potentiation (L TP) induces BDNF mRNA expression
(Bramham et aI., 1996).

In contrast, mice with deficient BDNF expression show

reductions in LTP (Bartoletti et aI., 2002; Abidin et ai., 2006). Interestingly, BDNFinduced BDNF mRNA induction is biphasic; early expression occurring after 1-3 hours
while delayed expression is manifested after 24 or more hours (Yasuda et aI., 2007).
Following transcription, BDNF mRNA is preferentially translated within the dendrites of
active synapses (Sterward and Schuman, 2001; Tongiorgi et aI., 1997). In addition,
BDNF is stored in large dense core vesicles in axons until it is released via tightlyregulated secretory pathways (Wu et aI., 2004). BDNF release from synaptic stores and
binding to TrkB receptors on post-synaptic targets is activity dependent (Kohara et aI.,
2001).
Chronic cocaIne alters BDNF protein expreSSIon In select nuclei within the
meso limbic pathway after extended but not early abstinence (Grimm et ai., 2003). These
areas include the NAc, BLA, and VTA. However, BDNF is anterogradely transported
and released in a Ca++ .. dependent manner in the NAc by dopaminergic neurons arising in
the VTA as well as from cortical glutamatergic pyramidal neurons (Altar et aI., 1997).
The striatum, including the NAc, expresses levels of BDNF mRNA that are only
detectable by peR amplification. In fact, most of the BDNF protein expression in the
striatum arises from anterograde transport from the cortex, rather than from midbrain
dopamine neurons (Altar et aI., 1997).

Moreover, little is known about the role of

cortico-striatal BDNF neurotransmission following different durations of withdrawal
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from sub-chronic cocaine self-administration. The present study examined the effect of
10 days of cocaine self-administration on BDNF expression within the PFC, NAc, and

CPu following 22 h or 21 d of withdrawal with or without a cocaine priming injection.

Materials and Methods

Subjects and experimental design
Male Sprague Dawley rats were used in both experiments. Figure 2-1 illustrates
the experimental design.

Rats in experiment one

underw~nt

either cocaine self-

administration or yoked-saline followed by either 22 hours or 21 days of abstinence. At
both 22 hours and 21 days of abstinence, rats were euthanized and tissue was harvested
for in situ hybridization histochemistry. Rats in experiment two underwent cocaine selfadministration or received yoked-saline infusions.

After self- administration, rats in

experiment two underwent either 22 hours of abstinence followed by a 30 min contextual
reinstatement test or 21 days of extinction training followed by a 2 hour cocaine-prime
reinstatement test.
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EXPERIMENT 1

abstinence

PFC BDNF mRNA Expression

EXPERIMENT 2

30 minute
extinction test

abstinence

PFC and NAc BDNF Protein Expression

2 hour
reinstatement test

training

Cocaine prime
(10 mg/kg)

Figure 2-1: Experimental design. Experiment 1 measured BDNF mRNA expression
via in-situ hybridization 22 hours or 21 days after 10 days of cocaine self-administration
or yoked-saline. Experiment 1 measured BDNF protein expression via ELISA 22 hours
or 21 days after 10 days of cocaine self-administration or yoked saline.

Training and surgery
Rats learned to press a lever to obtain a reward by undergoing a food training
session in which active lever presses (right lever, fixed ratio 1 schedule) resulted in the
delivery of a single 45 mg food pellet (Formula A/I; Research Diets Inc., New Brunswick~
NJ) in the absence of any presented stimuli. Food training sessions took place overnight
following a 24 h period of food deprivation. For the duration of the experiment, rats were
maintained at approximately 90% of their ad libitum weight in a climate-controlled room
on a reverse light/dark cycle. The day following successful completion of food training,
the rats were anesthetized with ketamine (64.68 mg/kg) and equithesin (Iml/kg) and
catheters were implanted into the right jugular vein (as described by See et aI., 2003).
17

Following surgery, animals received daily intravenous infusions (0.1 ml) containing the
antibiotic cefazolin (100 mg/ml) and the anticoagulant heparin (70 V/ml) until the
experiment was complete.

Self-administration

Following three days of recovery from surgery, rats were placed into standard
operant chambers (30 x 24 x 30 cm, Med Associates, 8t Albans, VT) for 120 min
sessions for 10 consecutive days. Each chamber was equipped with two levers (7 cm
above the floor), and a circular stimulus light 7 cm above each lever. The infusion line
was attached to a liquid swivel (Instech, Plymouth Meeting, PA) mounted on a suspended
counterbalance.

Half of the animals received response- (active, right lever presses)

contingent infusions of cocaine hydrochloride (0.2 mg/infusion; National Institute on
Drug Abuse, Research Triangle Park, NC) delivered by a computer-controlled infusion
pump with a 20 sec timeout period following each infusion. Responses on left (inactive)
levers had no programmed consequences, but were recorded.

The other half of the

animals received yoked-saline infusions, dependent upon the adjacent self-administration
box. These animals had access to the levers and presses were recorded but had no
programmed consequences.

Abstinence

Rats in experiment one underwent 22 hours of home cage abstinence following 10
days of cocaine self-administration (N=8) or yoked-saline infusions (N=7). Other rats
. from experiment one underwent 21 days of abstinence following 10 days of cocaine self-
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administration (N=9) or yoked-saline infusions (N=7).

During abstinence, all rats

remained singly housed in their respective home cages. To adjust for effects of handling
and altered scheduling, rats were handled daily and their home cages were moved and
placed into a different room during the time of the day that they had previously
undergone self-administration. Rats received the same amount of food (90% of their ad
libitum weight) during the abstinence period.

Extinction Training
Some rats in experiment one underwent 21 days of extinction training following
cocaine self-administration (N=9) or yoked-saline infusions (N=9).

These rats were

euthanized immediately following the final daily 2 h extinction session. Rats in
experiment two underwent either a single 30 min "extinction test" 22 hours following 10
days of cocaine self-administration (N=6) or yoked saline (N=6) or 21 days of extinction
training following 10 days of either cocaine self-administration (N= 11) or yoked-saline
infusions (N= 10). Extinction training sessions were held at the same time of day as the
self-administration sessions had been. During the extinction session, responding on the
active and inactive levers was recorded but had no programmed consequences.

Reinstatement testing
In experiment one, rats were sacrificed following either 22 h or 21 d of homecage abstinence or 21 days of extinction training, but they did not return to the selfadministration environment for any type of reinstatement testing.

However, in

experiment two, rats that underwent 21 days of extinction training were given a cocaine-
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primed reinstatement test for which each rat was injected with cocaine (10 mg/kg, i.p.) or
saline at the beginning of the test. During the cocaine-primed reinstatement test, lever
presses were recorded, but had no programmed consequences. At the end of this test, the
brains were harvested for BDNF protein analysis.

Tissue extraction

All rats were sacrificed by rapid decapitation. Rats that underwent reinstatement
testing were sacrificed immediately following the completion of the 2 h session. In
experiment one, brains were removed immediately and one hemisphere was frozen in
isopentane in preparation for in situ hybridization. In experiment two, whole brains were
removed and immediately frozen in isopentane for ELISA assays. Brains were sectioned
in a cryostat in a rostral to caudal then a caudal to rostral direction until the PFC, NAc,
and CPu were isolated and removed via a 13 gauge (2.1 mm i.d.) needle and immediately
weighed and stored at -80 DC.

In situ hybridization

The oligodeoxynucleotide probes were synthesized and purified by Invitrogen
(San Diego, CA).

The tissue was processed and analyzed as described (Gonzalez-

Nicolini et aI., 2003). Probes (5 J.lM) were labeled at the 3' end using alpha-esS]deoxyadenosine triphosphate (> 1000 ci/mmol, New England Nuclear, Boston, MA) and
terminal deoxynucleotidyl transferase (Roche Diagnostics Corp., Indianapolis, IN) in 5x
tailing buffer for 5 min. at 37DC to a specific activity of 7-12 x 105 cprn/J.ll. Ten mM
Tris-l mM EDTA and tRNA were added to stop the reaction. The sample was then
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centrifuged and 10 mM TE and 1 mM EDTA and 1 M OTT were added to a total volume
of 100 Jll. A 1J.lI aliquot. in 5 ml Ecoscint A (National Diagnostics) was counted in a
Beckman Coulter liquid scintillation counter. Frozen 12 Jlm sections were cut in a
cryostat and mounted onto gelatin-chromium-coated slides. Following fixation with 4%
paraformaldehyde and defatting in ethanol, each section was hybridized with 1xl 06 dpm
of a probe in hybridization buffer at 37°C for 20 hours. Following four washes in sterile
saline citrate/50% formamide at 40°C and two washes in sterile saline citrate, the sections
were dried. Slides were then placed into an x-ray film cassette along with 14C standards
(American Radiolabeled Chemicals, St. Louis, MO) and Kodak Biomax MR (Rochester,
NY) film was applied in a dark room at room temperature.

After 3-4 weeks of
-

development films were removed and hybridization levels were quantified using NIH
Image (W. Rasband, NIMH) v. 1.6 as described (Wang and McGinty, 1996). Briefly, 14C
standards were measured in order to construct a calibration curve by plotting these values
against known d.p.m.lmg. A "blank field" was created to eliminate uneven illumination
and background was subtracted. Using density slice optimization, the hybridization signal
was measured in the PFC of three adjacent coronal sections for each animal. Changes
were quantified by measuring both the number of labeled pixels per area and the mean
density of tissue in d.p.m.lmg and these measurements were multiplied together to
determine the integrated density. The mean ± S.E.M. of each of these measures was
calculated for each rat by averaging the values in three adjacent sections.
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BDNFELISA
BDNF levels were assessed using enzyme linked immunosorbent assay (ELISAEmax

Immunassay System, Promega Corp., Madison, WI) kits, according to the

manufacturer's protocol. Flat-bottom plates were coated with an anti-BDNF monoclonal
antibody (1: 1000) overnight. After blocking nonspecific binding, immobilized antiBDNF monoclonal antibody was incubated with brain tissue samples containing BDNF
protein or BDNF standards serially-diluted to prepare a standard curve, followed by antihuman BDNF polyclonal antibody (1 :500). The complex was bound using an IgY
antibody conjugated to horseradish peroxidase as a tertiary reactant. After repeatedly
washing unbound

conjugate,

plates were

incubated

with tetramethylbenzidine

chromagenic substrate, and color change was measured in an ELISA plate reader at
450 nm. Using this kit, BDNF can be quantified in the range 7.8-500 pg/ml.
Measurements given by the plate reader were calibrated against a standard curve prepared
1\

with human BDNF protein from Promega plotted in serial dilution with only R 2 >0.95
accepted. Adjusted concentrations of BDNF expression were normalized to the average
concentration of the control condition.

Statistics

Analysis of variance (ANOV A) was used to analyze cocaine intake (mg/kg) and
active and inactive lever presses during self-administration, extinction and reinstatement
testing. Significant interactions were further analyzed using Tukey's honestly significant
difference (HSD) tests. For the gene and protein expression data, an ANOVA was
performed on the mean integrated density values or calibrated concentration respectively.
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Significant interactions were further analyzed USIng Tukey's honestly significant
difference (HSD) tests. The probability level at which the null hypothesis was rejected
was p<O.05.

Results

Experiment 1
Operant responding during self-administration
Rats that self-administered cocaine demonstrated significant differences in active
lever presses over the last three days of self-administration compared to saline-yoked
controls (Figure 2-2, F=11.032, p=0.004). However, there was no significant difference
in inactive lever pressing between groups during the last three days of self-administration
(F=0.571, p=0.461), demonstrating a clear, learned association for the active lever. There
was no significant change in the number of cocaine infusions received over the ten days
of cocaine self-administration.
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Cocaine self-administration induced a significant decrease in BDNF mRNA
expression within the mPFC after 22 h of abstinence

BDNF mRNA expressIon within the mPFC was analyzed uSIng In situ
hybridization histochemistry 22 hours after 10 days of cocaine self-administration or
yoked-saline infusions. A unpaired, Student's t-test demonstrated a significant decrease
in BDNF mRNA expression within the mPFC of rats that self-administered cocaine
compared to yoked-saline controls (Figure 2-3, F=9.688, p=O.OlO).
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Figure 2-3. BDNF mRNA Expression Following 22 Hours of Abstinence. Twentytwo hours following 10 days of cocaine self-administration, BDNF mRNA is
significantly decreased in the mPFC of rats that self-administered cocaine compared with
yoked-saline controls. *p<O.OS.

Following 21 days of abstinence or extinction training from 10 days of cocaine selfadministration there was no change in BDNF mRNA within the mPFC]

Following 21 d of either home-cage abstinence or extinction training at the end of
10 d of cocaine self-administration or yoke- saline infusions, tissue from the PFC was
processed for in situ hybridization.

No significant difference in BDNF mRNA

expression was observed within the PFC of rats that had a history of cocaine selfadministration compared to yoked saline. Furthermore, there was no significant effect of
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extinction training on BDNF mRNA expression compared to rats that underwent homecage abstinence (Figure 2-4).
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Figure 2-4. PFC BDNF mRNA Expression Following 21 Days. Twenty-one days
after cocaine self-administration or yoked-saline infusions, there was no change in BDNF
mRNA expression within the PFC among any treatment groups. Saline abstinent=7,
cocaine abstinent=9, saline extinction=9, cocaine extinction=9.

Experiment 2
Self-administration and extinction responding on day 1

There were significant differences in active lever responding over the last three
days between rats that underwent either cocaine self-administration or yoked saline
(figure 2-5; F 1,11=7.89, p<0.05). Twenty-two hours after the 10th self-administration
session, a 30 min extinction test was conducted after which the brains were harvested for
BDNF protein expression measurements. Rats with a cocaine history exhibited
significantly greater active lever (F 1,11=5.76, p<0.05) and inactive lever (data not shown;
F 1,11=4.41, p<0.05) pressing during the 30 min test than those with a yoked-saline history.
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Figure 2-5. Self-administration and Extinction Behavior. Self-administration and
responding on the active lever in rats that self-administered cocaine and underwent a 30
min extinction test after 22 h of abstinence. The average self-administration was
calculated by averaging the active lever responding during the last three days of selfadministration. Cocaine self-administering rats had significantly higher rates of active
lever responding during self-administration and during the 30 min extinction test
compared to yoked saline (* p<O.OS).

Self-Administration and Reinstatement Behavior
One-way ANOVA analysis revealed a significant effect of group on active lever
pressing over the last three days of cocaine self-administration (Figure 2-6, F=6.22,
p<O.OS). Tukey' s HSD test revealed a significant increase in responding in both groups
of rats that self-administered cocaine compared to yoked-saline counterparts (p<O.OS).
One-way ANOV A analysis revealed a significant effect of group on active lever pressing
during the 2 h cocaine-prime induced reinstatement test (F=S.961, p<O.OS). Tukey' s HSD
test analysis revealed a significant increase in responding in rats from the cocaine prime
group compared to all other groups (p<O.OS in each case), but there was no significant
difference between any of the other groups. sal-coc F= 14.421 , p<O.OS).

A one-way

ANOV A revealed no significant effect of group on inactive lever responding during the
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last three days of self-administration (F=0.938, p>0.05), during extinction or during the 2
h cocaine-prime induced reinstatement test.
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Figure 2-6. Self-administration, extinction, and reinstatement responding on the
active levers. Left: Rats that self-administered cocaine (N=II) pressed the active lever
significantly more than yoked-saline rats (N=1 0) (* p<0.05). Middle: Responding during
extinction was not different among rats that had self-administered cocaine or received
yoked-saline. Right: Only rats that previously self-administered cocaine and also
received a cocaine prime (N=6) (10 mg/kg, i.p.) prior to the reinstatement session
demonstrated a significant increase in active lever responding compared with extinction
values (+ p<0.05) and all three of the other treatment groups (* p<0.05).

BDNF protein expression within the PFC and NAc is unchanged 22 h after cocaine
self-administration

BDNF protein expression was evaluated using ELISA in tissue punches from the
PFC that were harvested immediately following a 30 m extinction test 22 h after 10 d of
cocaine self-administration or yoked-saline infusions. BDNF expression within the PFC
was not significantly altered 22 h after cocaine self-administration compared to yoked
saline controls (Figure 2-7, p>0.05).

BDNF expression within the NAc also was not
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significantly altered by cocaine self-administration compared to yoked saline controls
(Figure 2-7, F= 1.507, p>0.05).
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Figure 2-7. BDNF Protein Expression After 22 Hours. BDNF protein expression is
unaltered following 22 h of abstinence from cocaine self-administration or yoked-saline
infusions.

BDNF protein expression in the PFC and NAc following cocaine-prime induced
reinstatement

BDNF protein expression was evaluated in tissue punches from the PFC and NAc
of rats that self-administered cocaine or yoked saline and underwent 21 d of extinction
training before a single cocaine prime-induced reinstatement session.

Immediately

following the 2 h session, rats were euthanized and the tissue was stored for ELISA
assays. An ANOV A revealed a significant interaction between groups on BDNF protein
expression levels within the PFC (F 3,36=3.92, p=0.016). A Tukey's HSD test revealed that
rats that self-administered cocaine, regardless of whether they received a cocaine prime
or not, demonstrated a significant increase in BDNF protein expression within the PFC
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compared to yoked-saline controls (Figure 2-8). Finally, there was no significant effect
of the cocaine prime alone on BDNF protein expression levels within the PFC. In
contrast, cocaine self-administration alone failed to alter BDNF protein expression within
the NAc (Figure 2-9). Furthermore, the cocaine prime (10 mg/kg) failed to produce
significant changes in BNDF protein expression within the NAc of rats that had cocaine
self-administration experience, although there was a trend towards an increase compared
(p=0.083) to an acute cocaine exposure in yoked-saline rats.

A one-way ANOVA

revealed a trend towards an effect of group on BDNF protein expression (expressed as
percent sal-sal) (F=6.76, p>0.05).
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Figure 2-8. PFC BDNF Protein Expression after 21 Days. BDNF protein expression
was significantly increased in the PFC in rats that self-administered cocaine for 10 d
compared to yoked saline controls after 21 d of extinction training (* p<0.05). There was
no significant acute effect of the cocaine prime on BDNF protein expression levels in the
PFC.
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Figure 2-9. NAc BDNF Protein Expression after 21 Days. BNDF protein expression
within the NAc was not significantly altered by cocaine self-administration following 21
d of extinction training, nor was it altered 2 h after a cocaine prime (10 mg/kg, i.p.).

Discussion
The present study demonstrated the effect of sub-chronic cocaIne selfadministration on the mRNA and protein expression of BDNF in the PFC and NAc after
22 h or 21 d of abstinence or extinction training with or without a cocaine priming
injection. BDNF mRNA expression within the PFC was suppressed 22 h following 10 d
of cocaine self-administration, suggesting a depression in cortical neuronal activity in
early abstinence. However, this suppression in BDNF mRNA recovered after 21 d of
abstinence or extinction training. In contrast, after 21 d of extinction training, there was
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a significant increase in BDNF protein expression within the PFC of rats that had selfadministered cocaine, independent of whether they received a single cocaine-priming
injection or not. This result sharply contrasts with a lack of change in BDNF expression
within the NAc after 21 d of extinction training with or without a cocaine prime. This
indicates that BDNF protein expression within the PFC is increasing over extended
durations of extinction as the result of cocaine self-administration. Together, this study
demonstrates that the effect of sub-chronic cocaine self-administration on BDNF
expression remains a dynamic process throughout abstinence or extinction training. This
emphasizes the point that long-term neuroadaptations induced by chronic exposure to
cocaine continue to be manifested even in the absence of cocaine.
The evidence from the present study demonstrates that BDNF mRNA levels
within the PFC 'are initially depressed but return to normal levels by 21 days. BDNF
mRNA is highly correlated with activity-dependent cortical plasticity (Lu 2003; Shieh
and Ghosh, 1999). Induction of LTP is associated with increases in BDNF mRNA within
the cortex (Bramham et ai., 1996; Morimoto et ai., 1998). Furthermore, depression of
cortical BDNF mRNA expression is associated with pathological states such as
schizophrenia and Alzeimer's disease (Connor et aI., 1997; Holsinger et ai., 2000;
Weickert et ai., 2005). Additionally, alterations in BDNF mRNA expression have been
observed following cocaine treatment in other studies. Specifically, acute and repeated
exposure to non-contingent cocaine transiently increases BDNF mRNA expression
within the PFC at 2 hours following cocaine administration (Le Foll et ai., 2005;
Fumagalli et ai., 2007). This increase is not preserved, and does not necessarily contradict
the present findings. Rather, it demonstrates the very dynamic nature of BDNF mRNA
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expression within the PFC following cocaine exposure. It is possible that the present
reductions in BDNF mRNA within the PFC may be a compensatory response to the
short-term increases in mRNA expression induced by cocaine. Also, decreases in BDNF
mRNA are not observed 21 days after cocaine self-administration, suggesting that this
effect may be only a "snapshot" in a fluctuating system with impaired homeostatic
balance.

Although cocaine-induced changes in BDNF mRNA expression may be

transient, considering the significant role BDNF

plays in the regulation of PFC

homeostasis (Rutherford et aI., 1998; Desai et aI., 1999; Leslie et aI., 2001) cocaineinduced oscillations during early withdrawal could lead to more long-term neuroadaptations in the PFC.
In contrast to the seemingly transient and dynamic changes in BDNF mRNA
expression within the PFC, the evidence from the present study suggests that cocaineinduced increases in BDNF protein expression within the PFC occur more gradually over
longer durations of withdrawal. Considering that we did not observe parallel changes in
both BDNF mRNA and protein expression within the PFC at either time-point, the
changes in BDNF protein expression are likely to be the result of post-transcriptional
mechanisms. An increase in BDNF protein expression within the PFC could result from
a number of different mechanisms and could have a number of different consequences.
Post-transcriptional alterations in BDNF expression within the PFC could be caused by
increases in trafficking of BDNF from efferent sources, a decrease in synaptic release and
uptake within local cortical efferents, an increase in the conversion of pro-BDNF to
mature BDNF, or a decrease in BDNF degradation. One must consider the depressed
state of PFC pyramidal neurons following withdrawal from repeated cocaine self-
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administration, a state commonly termed hypo-frontality (Sun and Rebec, 2006 ;
Goldstein and Volkow, 2002). Considering that BDNF is released normally from presynaptic stores in an activity dependent manner associated with increased glutamatergic
activity, during withdrawal a decrease in the local release of BDNF within the PFC may
result in an increase in BDNF that is sequestered pre-synaptically (Balkowiec and Katz,
2002; Hartmann et al,. 2001; Jovanovic et aI., 2000). This may serve to "prime" the
neurons within the PFC to elicit an enhanced response to drug-associated stimuli and
ultimately perpetuate the behavior that underlies addiction.
Increases in BDNF protein expression corresponding to increasing durations of
abstinence following cocaine has been demonstrated in other brain areas, including the
NAc, VTA, and BLA (Grimm et aI., 2003). Although we were unable to replicate this
finding within the NAc, a number of methodological differences in the selfadministration paradigm's used may account for this.

Specifically, in the study by

Grimm et aI., rats were given extended access to cocaine (6-8 hours) with a higher dose
of cocaine (1 mg/kg) compared to the 2 hour limited access paradigm at 0.6 mg/kg in the
present study. Also, in the Grimm et al study, changes in BDNF protein expression were
observed after 30 and 90 days of home-cage abstinence with the greatest changes seen
after 90 days. In the present study BDNF protein expression was measured following
only 21 days of extinction training. These differences suggest that increases in BDNF
protein expression within the NAc may be correlated with both the amount of cocaine
that was received as well as the duration of abstinence. Also, although we failed to see a
change in BDNF protein it is possible that the pro form of BDNF rather than the mature
form was altered within the NAc following cocaine (Fumagalli et aI., 2007).
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There is overwhelming evidence that the molecular alterations within the PFC,
specifically BDNF, may underlie the increase in the salience of cocaine-associated
stimuli, which drive cocaine-seeking behavior and relapse.

The present study lends

credence to this idea by demonstrating both the transient and persistent changes in
endogenous BDNF mRNA and protein expression within the PFC. It is still speculative,
but the perseverative response to cocaine-associated stimuli may be the direct result of
long-term changes in synaptic plasticity and morphology which are mediated by BDNF.
Very few, if any, studies have measured what effect directly altering BDNF activity
within the PFC would have on reinstatement. Therefore, in the next phase of this study,
we measured the effect of exogenous BDNF infusions within the PFC on reinstatement of
cocaine-seeking behavior.
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CHAPTER 3

A BDNF INFUSION INTO THE MEDIAL PREFRONTAL CORTEX
SUPPRESSES COCAINE SEEKING IN RATS

Introduction
Exposure to contexts or cues previously associated with drug taking, or reintroduction of the drug itself, can elicit reinstatement of drug seeking in animal models
of relapse (Spealman et aI., 1999; Alleweireldt et aI., 2001; Shaham et aI., 2003; See,
2005). The susceptibility to drug relapse and other addictive behaviors is thought to
depend on long-term neuroadaptations in mRNA, proteins and phospho-proteins (Kalivas
and Volkow, 2005). One of the proteins that has been implicated in the reinstatement of
cocaine seeking in rats is brain-derived neurotrophic factor (Lu et aI., 2004; Liu et aI.,
2006). BDNF protein expression increases in the ventral tegmental area (VTA), nucleus
accumbens (NAc) and amygdale of rats following 30 or 90 days of withdrawal from
cocaine self-administration (Grimm et aI., 2003). Furthermore, BDNF infusions into the
VTA or NAc enhance cocaine-induced behavioral sensitization (Horger et aI., 1999), and
increase cue- and cocaine-induced reinstatement, a long-term effect that is present for at
least 30 days of withdrawal (Lu et aI., 2004). Conversely, repeated administration of
BDNF antiserum into the NAc during chronic cocaine self-administration increases
cocaine-induced reinstatement (Graham etaI., 2007). Collectively, these studies implicate

BDNF activity in the VTA and NAc in long-term modulation of cocaine-induced
behavior. Cocaine-induced neuroadaptations are commonly manifested by alterations in
the postsynaptic plasticity of medium spiny neurons in the NAc. These alterations are
likely related to adaptations in prefrontal cortex (PFC) glutamatergic and VTA
dopaminergic afferents, both of which are critical mediators of reinstatement to cocaine
seeking triggered by conditioned stimuli (CS), context or cocaine itself (McFarland et aI.,
2003; McLaughlin & See, 2003; Fuclis et aI., 2004, 2005; Kalivas, 2004; Bachtell et aI.,
2005; Schmidt et aI., 2005). Withdrawal from cocaine self-administration elicits longterm decreases in NAc basal extracellular glutamate levels and associated intracellular
signaling (Pierce et aI., 1996; Xi et aI., 2002; Baker et aI., 2003). Thus, in addition to
neuroplasticity in the mesoaccumbens dopamine system, . long-term adaptations in the
PFC-NAc circuitry are critical for the reinstatement of cocaine seeking. Cortical
pyramidal -neurons are the predominant source of BDNF in the striatum (Altar et aI.,
1997), including the NAc. However, the significance of BDNF in the PFC to cocaineinduced motivated behavior has not been investigated. Based on the importance of the
cortico-accumbens pathway for reinstatement and the significant role of BDNF in the
activity of this pathway, in the current study we evaluated the effects of a BDNF infusion
into the PFC on several forms of cocaine-seeking behavior, on food-seeking behavior, as
well as on the expression of BDNF -and phospho-extracellular-regulated kinase (ERK), a
major BDNF-TrkB signaling protein, in the NAc and caudate putamen. We hypothesized
that 'infusion of BDNF into the medial (m)PFC would enhance reinstatement of drug
seeking, based on findings that a bilateral BDNF infusion into the VT A immediately after
the final cocaine self-administration session augmented cocaine seeking (Lu et aI., 2004).
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However, we found the opposite, that intra-PFC BDNF, when administered immediately
after the final cocaine self-administration session but not 6 days later, suppressed cocaine
seeking triggered by CS, context or cocaine itself. These data expand our understanding
of the complex role of BDNF in the regulation of addictive behavior.

Materials and Methods
Animals
Male Sprague-Dawley rats (n = 84; Charles River Laboratories, Wilmington, MA,
USA), weighing 275-325 g at the time of surgery, were housed individually on a reverse
light: dark cycle. Rats were maintained on 20-25 g of rat chow per day, with water
available ad libitum. All protocols were approved by the Institutional Animal Care and
Use Committee of the Medical University of South Carolina, and carried out In
accordance with the National Institutes of Health Guide for the Care and Use of
Laboratory Animals (NIH Publications no. 80-23, revised 1996).

Lever response training
Rats were trained to lever press on a fixed ratio 1 schedule of food reinforcement
(45 mg pellets; Noyes, Lancaster, NH, USA) in sound-attenuated operant conditioning
chambers (30 . 20 . 24 cm high; Medical Associates, St Albans, VT, USA) during a 16 h
overnight training session. The chambers were equipped with two retractable levers, a
stimulus light above each lever, a food pellet dispenser between the levers, a house light
on the wall opposite the levers, and a speaker connected to a tone generator (ANL926,Medical Associates). During the session, each lever press on the active lever resulted
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in delivery of a food pellet only. Lever presses on the inactive lever had no programmed
consequences. Following food training, food pellet dispensers were removed from the
chambers.

Surgery

At 48 h after food training, rats were anesthetized using a mixture of ketamine
hydrochloride (66 mg/kg i.p.; Fort Dodge Animal Health, Fort'Dodge, lA, USA) and
xylazine (1.33 mg / kg Lp.; Bayer, Shawnee Mission, KS, USA) followed by equithesin
(0.5 mL/kg). Catheters constructed of silastic laboratory tubing (0.64 mm Ld., 1.19 mm
o.d.; Dow Coming, Midland, MI, USA) were implanted into the right jugular vein of rats,
and were anchored to the vein with silk suture and a hardened silicon gel ball (silicon
rubber sealant; General Electric, Waterford, NY, USA) placed 33 mm from the anterior
end of the catheter. The silastic tubing ran directly under the skin to an exit point located
in the mid-scapular region. The open end of the catheter cannula was enclosed with a
short piece of polyethylene tubing that had been heat sealed, and the threaded region of
the cannula was

cov~red

with a threaded plastic cap when not in Use. Immediately

following catheter implantation, rats were mounted onto a stereotaxic device (Stoelting,
Wood Dale, IL, USA), and bilateral stainless steel cannulae (26 gauge, Plastics One,
Roanoke, VA, USA) were implanted 1 mm above the PFC target region (AP=+3.0; ML=
+0.6; DV=1.6), relative to bregma, Paxinos & Watson, 1998). Following implantation,
guide cannulae were secured to the skull with cranioplastic cement and three steel
machine screws. Stylets (Plastics One) were placed into the guide cannulae to prevent
blockage. Following surgery, rats were infused i.v. with 0.1 mL each of cefazolin (100
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mg / mL) and heparinized saline (70 U / mL) once daily during a 5 day recovery period. '
Catheter patency was verified by infusing 0.1 mL of methohexital sodium (20 mg / mL,
i.v.; Eli Lilly, Indianapolis, IN, USA), which produces a rapid loss of muscle tone only
when administered intravenously.

Cocaine self-administration
Cocaine self-administration was conducted in standard self-administration operant
chambers (30 X 20 X 24 cm; Medical Associates).

Each chamber contained two

retractable levers (7 cm above the chamber floor) on each side of the front wall. A white
circular stimulus light (2.5 W, 24 V bulb) was located on the panel 7 cm above the active
. (right) lever, and a red house light (2.5 W, 24 V bulb) was located on the wall on the
opposite end of the chamber. The infusion line was tethered to a liquid swivel (Instech,
Plymouth Meeting, PA, USA) mounted on a suspended counterbalance. The selfadministration apparatus was enclosed in a sound-attenuating chamber (Medical
Associates). Cocaine hydrochloride (4 mg/mL; National Institute on Drug Abuse/RTI
International, Research Triangle Park, NC, USA) was delivered using a computercontrolled infusion pump located outside the chamber. The entire system was computer
controlled using Medical PC for Windows.

Rats self-administered cocaine on 10

consecutive days during 2 h daily sessions. Figure 1 illustrates the experimental design of
each of the experiments. Rats received 0.1 mL of heparinized saline (IOU / mL, Lv.)
prior to each self-administration session. Animals were then connected to the infusion
tether and each session began immediately, signaled by the movement of both levers into
the chamber. With the exception of the yoked-saline rats fronl Experiment 1, cocaine

39

reinforcement was available on a fixed ratio 1 schedule of reinforcement explicitly paired
with a compound CS consisting of illumination of a white stimulus light located above
the active lever and a tone (2 kHz, 15 dB above ambient noise). Responses on the active
(right) lever resulted in the delivery of cocaine (0.2 mg /0.05 mL bolus) over 2 s, and
each infusion was followed by a 20 s 'time-out' period. During the time-out, active lever
presses were recorded, but had no programmed consequences. Responses on the inactive
(left) lever were also recorded, but had no programmed consequences. Yoked-saline rats
(Experiment 1) see below) received an infusion of saline (0.05 mL bolus) over 2 s,
contingent upon the cocaine infusion received by the self-administering rat in the
adjacent self-administration chamber. Rats underwent 10 days of cocaine selfadministration prior to a single intracranial infusion.

Intracranial infusions

We adapted the single infusion protocol and chose the dose of BDNF (0. 75

~g /

side) that Lu et al. (2004) previously used in vivo. For BDNF or vehicle (10 mM
phosphate-buffered saline) (PBS) infusions, infusion cannulae (33 gauge; Plastics One)
were inserted bilaterally into the guide cannulae such that 1 mm of the infusion calmulae
extended past the end of the guide cannulae.

Human recombinant BDNF (R & D

Systems, Minneapolis, MN, USA) or vehicle (sterile PBS) was infused using gas-tight
Hamilton syringes (10 J.1L) and an infusion pump (Harvard Apparatus, Holliston, MA,
USA).

~

volume of 0.5

~L

was infused over 2 min, and the infusion cannulae remained

in the guide cannulae for 1 min before and after the infusion.
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Abstinence, extinction and reinstatement

Figure 1 illustrates the experimental designs for all the studies. Experiment 1 was
conducted to determine if infusion of BDNF immediately following the last selfadministration session would alter the first day of extinction responding and to harvest
tissue for BDNF and phospho-ERK measurements. In Experiment la, uncannulated rats
self-administered cocaine or received yoked-saline for 10 days. After 22 h abstinence, .
they were placed back into the self-administration environment for a 30 min extinction
test during which the rats were allowed to press on either the active or inactive lever
without any programmed consequences. At the end of the 30 min test, they were
decapitated, and the NAc and caudate putamen were harvested for phospho-protein and
BDNF protein measurements. In Experiment 1b, cannulated rats received an intra-PFC
infusion of either BDNF or vehicle immediately following the final (10th) cocaine selfadministration session. Rats in Experiment 1b were also placed back into the selfadministration environment for a 30 min extinction test following 22 h of abstinence
from cocaine self-administration. At the end of the 30 min test, they were decapitated and
the brains were harvested for histological verification of cannulae sites (PFC), and
phospho-protein and BDNF protein measurements (NAc and caudate putamen). Tissue
from Experiments 1a and 1b was processed, assayed and analyzed together for
comparative purposes.
Experiment 2 was performed to investigate whether BDNF would alter: (a)
relapse to cocaine seeking elicited by discrete light + tone cues in the self-administration
context in abstinent rats; (b) reinstatement of cocaine seeking elicited by the light + tone
cues in rats that underwent 6 days of extinction training; and (c) reinstatement of cocaine
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seeking elicited by a cocaIne-prImIng injection in the same rats that underwent an
additional 6 days of extinction training which was sufficient to reach extinction criterion
agaIn.

Cannulated rats received an intra-PFC infusion of either BDNF or vehicle

immediately following the final (10th) self-administration session. The rats remained in
the home cage for 6 days following the last self-administration session. On abstinence
day 7, rats underwent a 2 h test in the self-administration chambers, in which each active
lever press resulted in a contingent 5 s presentation of the light + tone CS (with a 20 s
time-out) in the absence of cocaine reinforcement. Rats continued for six daily extinction
sessions in which lever presses had no programmed consequences, and were then tested
during a 1 h extinction phase followed immediately by a 1 h cue-induced reinstatement
test. During the cue reinstatement test, active lever presses resulted in light + tone CS
presentations in the absence of cocaine reinforcement. Following 6 additional days of
extinction, rats underwent a 1 h extinction session followed by a 30 min cocaine-primed
reinstatement test for which each rat was injected with cocaine (10 mg / kg, i.p.) at the
beginning of the test. During the cocaine-primed reinstatement test, lever presses were
recorded, but had no programmed consequences. At the end of this final test, the brains
were harvested, after decapitation, for histological verification of cannulae sites, and
phospho-protein and BDNF protein analysis. Experiment 3 was conducted to detennine if
BDNF would suppress cocaine seeking in abstinent rats if it was infused into the mPFC
22 h before the test instead of immediately following the last self-administration session.
In this experiment, rats remained in the home cage (abstinence) for 6 days following the
last self-administration session. On the 6th day of abstinence, rats received an intra-PFC
infusion of BDNF or vehicle, but did not return to the self-administration environment.
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On abstinence day 7, rats underwent a 2 h test in the self-administration chambers, in
which each active lever press resulted in a contingent 5 s presentation of the light + tone
CS (with a 20 s time-out) in the absence of cocaine reinforcement. At the end of the
experiment, the rats were decapitated and the brains were harvested for histological
verification of cannulae sites.
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Fig. 3-1. Experimental Paradigm. Schematic diagram of the experimental paradigms
used in experiments 1-4.

Food self-administration and reinstatement
Experiment 4 was designed to be as similar as possible to the design of the
abstinence and cue-induced reinstatement phases of Experiment 2, except that the rats
learned to ~lf-administer food instead of cocaine. Rats initially lever-pressed for food
reinforcement (45 mg Noyes food pellets) on a fixed ratio 1 schedule of reinforcement,
during daily 2 h sessions on 10 consecutive days. Subjects then remained in the home
cage for a 6 day abstinence period, during which they were maintained at 90% ad libitum
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weight. Rats then underwent a 2 h post-abstinence test, during which active lever
pressing resulted in the presentation of the previously paired light + tone but no food.
Following 6 days of extinction training, during which lever presses were recorded but
never resulted in food pellet or CS delivery, rats underwent a cue-induced reinstatement
test for food-seeking behavior. During the cue-induced reinstatement test, active lever
presses resulted in the presentation of the CS previously paired with food during selfadministration. The 1 h test was preceded by 1 h of extinction training.

Tissue processing and histology

Rats in Experiments 1-4 were killed by rapid decapitation following the
completion of the final extinction or reinstatement test. Brains were immediately
removed and frozen in isopentane, then stored at 800 C until they were sectioned on a
cryostat. Sections through the PFC were sectioned at 12

~m

for cannulae placement

verification. The remaining forebrain from rats in Experiments 1 and 2 was sectioned
from rostral to caudal up to AP 1.7 from bregma. It was then removed from the chuck
and sectioned caudal to rostral up to AP 0.7 from bregma. The remaining slab of tissue
contained the dorsal and ventral striatal target areas that were extracted using a 13 -gauge
tissue punch. Frozen punches were stored at -80 0 C prior to being processed for
immunoblotting.

'-~

Immunoblotting

The method described by Toda et al. (2003) was used. Protein was extracted from
both the NAc and caudate putamen, and the tissue was sonicated in Trizol (Invitrogen,
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Carlsbad, CA, USA). Samples were analyzed for protein, diluted to equalize for the
protein concentrations, and aliquoted. Samples were stored in the sample buffer [TrisHCI, 0.5 mm, pH 6.8; glycerol 10%; sodium dodecyl sulfate (SDS) 10%; bmercaptoethanol, 5%; bromophenol blue, 0.05% w Iv], boiled for 2 min and loaded onto
gels (12% SDS). Proteins were separated by application of 30 rnA constant current for
25-30 min, transferred onto polyvinylidene fluoride (PVDF) membrane strips (200 rnA
for 60 min; Millipore, Billerica, MA, USA), and immunoblotted with anti-phospho-ERK
1 I 2 (1 : 500-phospho-p44 I 42 MAP kinase, Thr202 I Tyr204, Cell Signaling
Technologies, Danvers, MA, USA) for 60 min at room temperature. PVDF strips were
washed and incubated for 60 min at room temperature with secondary antibody
[horseradish peroxidase (HRP)-linked anti-rabbit antibody 1 : 1000; Amersham
Biosciences, Piscataway, NJ, USA] and protein complexes were visualized by enhanced
chemiluminescence ECL detection (Amersham Biosciences). Irnrnunoblots were exposed
('

to Hyperfilm (Amersham Biosciences). Following imaging, membranes were incubated
for 10 min in stripping agent (re-blot plus Western blot mild antibody stripping solution;
Chemicon International, Temecula, CA, USA) and then re-exposed to primary antibody
specific for non-phosphorylated ERK 1 I 2 (1: 1000) overnight. Protein bands were
quantified by densitometry using Image J software. Analyses were performed by
evaluating the ratio of phospho-ERK I total ERK expression of each sample within a
single membrane. The ratio was normalized across trials (a minimum of three
comprehensive, individual trials was performed for each experiment) by expressing each
ratio value as a percentage of the control within each individual trial.
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BDNF enzyme-linked immunosorbent assay (ELISA)

BDNF levels were assessed using ELISA-Emax Immunoassay System (Promega,
Madison, WI, USA) kits, according to the manufacturer's protocol. Flat-bottom plates
were coated with an anti-BDNF monoclonal antibody (1: 1000) overnight. After blocking
non-specific binding, immobilized anti-BDNF monoclonal antibody was incubated with
brain tissue samples containing BDNF protein or BDNF standards serially diluted to
prepare a standard curve, followed by anti-human BDNF polyclonal antibody (1 : 500).
The complex was bound using an IgY
After

repeatedly

washing

antibo~y

unbound

conjugated to HRP as a tertiary reactant.

conjugate,

plates

were

incubated

with

tetramethylbenzidine chromagenic substrate, and color change was measured In an
ELISA plate reader at 45)) nm. Using this kit, BDNF can be quantified in the range 7.8500 pg / mL. Measurements given by the plate reader were calibrated against a standard
curve prepared with human BDNF protein from Promega plotted in serial dilution with a
correlation coefficient of r2> 0.95 accepted. Adjusted concentrations of BDNF expression
were normalized to the average concentration of the control condition.

Statistical analysis

Responding on both the active and inactive levers across groups during relapse to
cocaine seeking was compared with responding during the last 3 days of selfadministration or responding during the extinction session that preceded the test as
appropriate in each of the studies. Due to the

experimenta~

design (multiple observations

per rat) the data are correlated, so a statistical model capable of accounting for this
correlation was used for the behavioral data to avoid biased P-values (Fitzmaurice et aI.,
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2004). Further, the response variables (number of active and inactive lever presses) are
,'count' data, so an approach that does not assume normality was selected. To address
both of these issues in the statistical analysis, a generalized estimating equation approach
using a Poisson distribution (Litrell et aI., 2002) was implemented using SAS v9.1 (SAS
Institute, Cary, NC, USA), with treatment (e.g. BDNF or vehicle) and condition (e.g.
extinction or cocaine challenge) as explanatory covariates (factors).

Generalized

estimating equation methods were first proposed by Liang & Zeger (1986), and details of
their statistical properties are further described by Fitzmaurice et aI. 2004.

These

methods are similar to mixed model analyses of variance (ANOVAs), as both explain a
r-

correlated response variable with explanatory covariates) ANOV A is used for response
data that are normally distributed, whereas generalized estimating equations are used for
binary or count data. Generalized estimating equations use a chi-square because it is
effectively doing two analyses: one with no covariates and another with all of the
covariates of interest. It then does a goodness of fit test comparing the improvement in
the model with covariates over the model without them. For data that were approximately
normally distributed (immunoblotting and ELISA), a mixed model ANOV A was
performed and multiple comparisons were adjusted via the Tukey-Kramer test (for
unequal n per group) when a significant F-value was obtained. P-values < 0.05 \vere
considered statistically significant.

Results
Histology

Figure 2 illustrates the placement of infusion cannula tips in the mPFC (anterior
cingulate or prelimbic cortex) of rats that received bilateral BDNF or vehicle infusions in
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all experiments. Subjects with cannula tracts that did not meet the criteria of bilateral
placement in anterior cingulate or prelimbic cortex were not included in the schematic,
and the data from these animals (n = 4 from Experiment 1, n= 3 from Experiment 2, n= 1
from Experiment 3, n=1 from

E~eriment

4) were excluded from analysis. After

histological verification, the experimental groups were as follows: Experiment 1: cocaine
self-administering (no cannulae) (n = 8), yoked saline (no cannulae) (n = 10); intra-PFC
BDNF (n = 9), intra-PFC vehicle (n = 7); Experiment 2 (cocaine self-administering):
intra-PFC BDNF (n = 12) and intra-PFC vehicle (n = 12); Experiment 3: intra-PFC
BDNF (n = 12) and intra-PFC vehicle (n = 11); Experiment 4 (food self-administering)
intra-PFC BDNF (n = 5) and intra-PFC vehicle (n = 7).
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Fig. 3-2. Cannula Placement within
the PFC. Representation of the most
ventral point of the infusion cannulae
Measurements
within the mPFC.
correspond to distance from bregma in
millimeters (Paxinos and Watson,
1998).

Experiment 1: Intra-PFC BDNF infusion suppressed extinction responding,
increased BDNF protein in NAc, and prevented a cocaine-induced decrease in
phospho-ERK in NAc
All rats exhibited stable active (right) lever responding over the last 3 days of selfadministration that did not differ between treatment groups (mean ± SEM for vehicle
52.19 ± 5.74; for BDNF 51.60 ± 4.40;

t

= 0.01; dft; P > 0.9). Twenty-two hours after

the 10th self-administration session, a 30 min extinction test was conducted after which
the brains were harvested for phospho-protein measurements. Rats with a cocaine history
exhibited significantly greater active lever pressing during the 30 min test than those with
a yoked-saline history (Fig. 3A, leftX2= 52.3; dft; P < 0.001). Rats with a cocaine history
that had been infused with BDNF responded significantly less on the active lever than the
vehicle-infused rats with a cocaine history (Fig. 3A, right X2 = 4.3; dft; P < 0.05). There
was no significant difference in inactive lever pressing between groups during the 30 min
extinction test (X2 = 1.l; dft; P

=

0.3). BDNF protein in the NAc of rats that received an

intra-PFC BDNF infusion 22 h before the extinction test was significantly greater than in
the NAc of rats in the other three groups (ANOVA F3,28 = 6.0; P < 0.01, Fig. 3.8). In
contrast, there was no difference between groups in BDNF protein expression in the
caudate putamen (data not shown). Interestingly, there was a significant decrease in
phospho- ERK expression within the NAc of uncannulated and cannulated (vehicletreated) rats with a cocaine history compared with yoked saline control rats (ANOV A Fz,'i'
= 15.5, P < 0.0001, Fig. 3C). In contrast, phospho-ERK expression within the NAc was
greater in rats that received intra-PFC BDNF infusions than in intra-PFC vehicle infused
rats (Tukey Kramer, P < 0.005) or in uncannulated cocaine self-administering rats (P <
0.000 1). There was, however, a significant effect of cocaine self-administration on
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phospho-ERK / total ERK expression within the caudate putamen in the presence or
absence of BDNF infusion (F3,15= 3.2, P < 0.05, Fig. 3D). Pair-wise comparisons (Tukey
Kramer) revealed a significant decrease in phospho- ERK / total ERK expression in
uncannulated rats that self-administered cocaine (P < 0.05), and rats that selfadministered cocaine and received intra-PFC vehicle (P < 0.01) or BDNF (P < 0.05)
compared with yoked-saline controls.
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Fig. 3-3. Intra-PFC brain-derived neurotrophic factor (BDNF) suppressed cocaineseeking behavior during a 30 min extinction test after 22 h of abstinence, increased
BDNF protein, and normalized phospho-extracellular regulated kinase (pERK)
levels in the NAc. Data are expressed as the mean number of active lever presses ± SEM.
(A) Rats with a cocaine self-administration history (n = 8) press the active lever
significantly more during a 30 min extinction test than yoked-saline rats (n = 10, ***p <
0.001). (B) A bilateral intra-PFC infusion of BDNF attenuated cocaine-seeking behavior
during the 30 min extinction test in rats with a cocaine history. The BDNF-treated rats (n
= 9) exhibited significantly fewer active lever presses during the 30 min extinction test
than the vehicle-treated rats (n = 7, *p < 0.05). (C) Rats with a cocaine history' (n = 9)
that received a bilateral intra-PFC infusion ofBDNF 22 h prior to a 30 min extinction test
exhibited significantly greater BDNF protein expression within the NAc than cannulated,
vehicle-infused rats (n = 9), uncannulated rats (n = 6) with a cocaine history, or salineyoked controls (n = 8, **p < 0.01). (D) Cocaine-self-administration significantly
decreased the phospho-ERK / total ERK ratio within the NAc of both uncannulated rats
(***P < 0.001) and rats that received a bilateral infusion of vehicle (PBS) into the PFC
(***P < 0.001), as compared with uncannulated saline controls. In contrast, intra-PFC
BDNF infusions following cocaine self-administration prevented the decrease in
phospho- ERK / total ERK ratio induced by cocaine self-administration. n = 7-8 per
group. (E) Cocaine self-administration significantly decreased the phospho- ERK / total
ERK ratio within the- caudate putamen (CPu) of both uncannulated rats (*P < 0.05) and
rats that received a bilateral infusion of vehicle (PBS) into the PFC (* *p < 0.01), as
compared with saline controls. However, intra-PFC BDNF infusions following cocaine
self-administration did not prevent the decrease in phospho-ERK / total ERK ratio
induced by cocaine self-administration (*P < 0.05). n = 4 per group.

Experiment 2: Intra-PFC BDNF infusion, immediately after the last cocaine
exposure, suppressed responding following abstinence and cue- and cocaineinduced reinstatement following extinction
Test 1: post-abstinence test
The effect of an intra-PFC BDNF infusion on cocaine seeking was evaluated after
6 days of abstinence (Fig. 4A). During the 2 h test, lever presses resulted in the responsecontingent presentation of the light + tone CS only. The vehicle-treated group (X2= 7.99;
dft; P

= 0.005), but not the BDNF-treated group (X2 = 0.27; dfl; P = 0.6), responded

significantly more on the active lever during the post-abstinence test than during the last
3 days of self-administration. Furthermore, the intra-PFC BDNF-infused rats responded
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significantly less on the active lever than the vehicle-infused rats during the extinction
test (X2= 11.43; dfl; P < 0.001). Additionally, vehicle-treated (X2= 665.5; dfl; P < 0.001)
and BDNF-treated (X2= 19.2; dfl; P < 0.001) rats responded significantly more on the
inactive lever during the post-abstinence test compared with the last 3 days of cocaine
self-administration, as reported previously (Fuchs et aI., 2006).

Test 2: cue-induced reinstatement
Following Test 1 and 6 days of extinction training, during which there were no
differences in the extinction rate or amount of lever pressing between groups (data not
shown), the rats underwent a cue-induced reinstatement test that consisted of a 1 h
extinction phase and a 1 h cue phase (Fig. 4B). During the cue phase, active lever
pressing resulted in contingent presentation of the light + tone CS. Vehicle-treated rats
responded significantly more on the active lever during the cue test than in the preceding
hour of extinction (X2 = 8.01; dfl; P

=

0.005). In contrast, the intra-PFC BDNF-infused

rats responded less than the vehicle-treated rats on the active (X2= 17.8; df,; P < 0.001)
and inactive (X2 = 4.05; dfl; P

=

0.04) lever during the cue test.

Test 3: cocaine-induced reinstatement
Following 6 additional days of extinction training, during which there were no
dif~erences

in the extinction rate or amount of lever pressing between groups (data not

. shown), the rats underwent a cocaine-primed reinstatement test (Fig. 4C). This consisted
of a 1 h extinction phase and a 30 min cocaine test phase (timed in order to harvest brains
for phospho-ERK measurements that decline rapidly). At the end of the extinction

phase~

rats received an injection of cocaine (10 mg/kg, i.p.). Because the extinction phase was
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longer than the cocaine prime test phase, only the average number of lever presses during
the last 30 min of extinction was ?ompared with that during the 30 min cocaine prime
test. Vehicle-treated rats responded significantly more on the active lever during the 30
min cocaine prime test than during the preceding 30 min of extinction (X2 = 24.82; dfl; P
< 0.001), demonstrating reinstatement of cocaine seeking. Once again, the intra- PFC
BDNF-infused rats pressed the active lever significantly less than the intra-PFC vehicleinfused rats during the cocaine-primed reinstatement test (X2 = 4.8; dfl; P < 0.05). There
was no significant difference in inactive lever pressing during the cocaine-induced
reinstatement session between groups (X2 = 2.96; dfl; P > 0.05) or during extinction (X2

= 0.06; dfl; P > 0.5). There was no significant difference in phospho-ERK expression in
the NAc (Fl,20 = 0.12; P = 0.735) or the caudate putamen (Fl,18 = 0.00; P = 0.996) of
intra-PFC BDNF-treated rats as compared with intra.-PFC vehicle-treated rats 30 min
after the cocaine infusion.
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Figure 3-4. A bilateral intra-PFC infusion of brain-derived neurotrophic factor
attenuated cocaine-seeking behavior. Data for vehicle- and BDNF treated rats are
expressed as mean ± SEM. n = 12 per group. (A) Left: there was no difference in the
number of active or inactive lever presses by rats subsequently treated with intra-PFC
BDNF or vehicle during the last 3 days of cocaine self-administration (Veh SA vs BDNF
SA). Right: after 6 days of abstinence, vehicle-treated rats exhibited a significant increase
in responding during the post-abstinence test when compared with cocaine selfadministration (++P < 0.01). Both BDNF- and vehicle-treated rats exhibited a significant
increase in inactive lever pressing during the post-abstinence test compared with cocaine
self-administration (+++P < 0.001). Furthermore, the BDNF treated rats exhibited
significantly fewer active lever presses during the post abstinence test than the vehicletreated rats (***P = 0.001). (B) Left: after 6 days of extinction training, the number of
active or inactive lever presses during the hour of extinction that preceded the cueinduced reinstatement test was not significantly different between groups. Right: the
intra-PFC vehicle treated rats responded more on the active lever during the cue test than
during the preceding hour of extinction (first ++P < 0.01). The BDNF-treated rats
exhibited significantly fewer active (***P < 0.001) and inactive (*P < 0.05) lever presses
during the cue-induced reinstatement test than vehicle-treated rats. (C) Left: the number
of active or inactive lever presses during the 30 min of the extinction phase that preceded
the 30 min cocaine-primed reinstatement test was not different between treatment groups.
Right: vehicle-treated rats exhibited a significant increase in responding during the
cocaine-prime test compared with the extinction phase (+++P < 0.001). The BDNFtreated rats exhibited significantly fewer active lever presses during the cocaine-induced
reinstatement test than the vehicle-treated rats (*P < 0.05).

Experiment 3: An intra-PFC BDNF infusion on the 6th day of abstinence does not
alter cocaine-seeking behavior
Post-abstinence test
The effect of a BDNF infusion into the PFC on the 6th day of abstinence was
evaluated during a 2 h post-abstinence test. During the 2 h test, rats were allowed to lever
press in the self-administration environment in the absence of drug reinforcement, but in
the response contingent presence of the light + tone CS (Fig. 5). Both vehicle treated (X2
=

78.8; dfl; P < 0.001) and BDNF-treated (X2

=

13.8; dfl; P < 0.001) rats exhibited

significantly more active lever pressing during the 2 h test than during the last 3 days of
cocaine self-administration. Additionally, both vehicle-treated (X2= 11.8; dfl; P < 0.001)
and BDNF-treated (X2 = 9.39; dfl; P

=

0.002) rats exhibited significantly more inactive
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lever pressIng during the 2 h test than during the last 3 days of cocaIne selfadministration. However, there was no difference between groups in active (X2= 0.47; dft;
P = 0.5) or inactive (X2 = 0.35; dfl; P = 0.6) lever pressing.
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Fig. 3-5. An intra-PFC infusion of BDNF after 6 days of abstinence failed to
significantly alter cue/contextual reinstatement to cocaine-seeking behavior. Data
fot vehicle (N=ll) and BDNF-treated (N=12) rats are expressed as mean ± SEM. Left:
The number of active and inactive lever presses over the last three days of selfadministration did not differ between treatment groups. Right: BDNF -treated rats
showed a significant increase in both active (++P<O.OI) and inactive (++P=O.OI) lever
presses during the 2-hour post-abstinence test compared with self-administration.
Vehicle-treated rats also showed significant increase in both active (+++P<O.OO 1) and
inactive (++P=O.O 1) lever presses during the 2-hour post-abstinence test compared with
self-administration.

Experiment 4: Intra-PFC BDNF infusion does not alter food self-administration or
cue-induced reinstatement of food-seeking
Test 1: post-abstinence test
The effect of a BDNF infusion into the PFC on food-seeking behavior was
evaluated after 6 days of abstinence. During the 2 h test, rats were allowed to lever press
in the self-administration environment in the absence of food reinforcement, but in the
response-contingent presence of the light + tone CS (Fig. 6A). Statistical analysis
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revealed that vehicle-treated (X2= 36.9; dfl; P < 0.001) and BDNF-treated (X2= 13.0; dfl;
P < 0.001) rats showed significantly lower active lever responding during the first
extinction session compared with the last 3 days of food self-administration. However,
active lever responding during the post-abstinence test did not differ between BDNF - and
vehicle-treated rats. In addition, both vehicle-treated (X2 = 6.4; dfl; P = 0.002) and BDNFtreated (X2

=

4.29; dfl; P

=

0.04) rats showed significantly higher inactive lever

responding during the 2 h test than during the last 3 days of food self-administration.

Test 2: cue-induced reinstatement
Following 6 days of extinction training, rats underwent a cue-induced
reinstatement test that consisted of a 1 h extinction phase and a 1 h cue phase (Fig. 6B).
During the cue phase, active lever presses resulted in contingent presentation of the light
+ tone CS. Statistical analysis revealed that both BDNF-treated (X2= 2.83; dfl; P

=

0.04)

and vehicle-treated (X2 = 40.07; dfl; P < 0.001) rats exhibited a significant increase in
active lever responding during the cue-induced reinstatement test relative to extinction.
However, there was no difference in active lever presses between the vehicle-treated and
BDNF-treated groups (X2= 0.94; dfl; P = 0.33). In addition, there were no differences in
inactive lever presses between groups during either the extinction phase or the cue test.
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Fig. 3-6. An intra-PFC infusion of BDNF failed to significantly alter cue/contextual
reinstatement of food-seeking behavior. Data for vehicle (N=7) and BDNF-treated
(N=5) rats are expressed as mean ± SEM. (A) Left: Active or inactive lever presses
during the last three days of food self-administration (Veh SA vs. BDNF SA) did not
differ between treatment groups. Right: Rats in both the vehicle-treated (+++P<O.OO 1) and
BDNF-treated (++P<O.Ol) groups exhibited significantly less active lever responding
during the post-abstinence test as compared to responding during the last three days of
self-administration. However, rats in both the vehicle-treated (++P<O.Ol) and BDNFtreated (+P<O.05) groups exhibited significant increases in inactive lever pressing during
the post-abstinence test compared to responding during the last three days of selfadministration. (B) Left: The number of active or inactive lever presses during the hour
of extinction that preceded the cue test did not significantly different between treatment
groups. Right: Both vehicle- treated (+++P<O.OOl) and BDNF-treated (+P<0.05) groups
exhibited a similar increase in active lever responding during the cue-induced
reinstatement test relative to extinction.
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Discussion
The present study represents the first report to examine the role of PFC BDNF in
cocaine-motivated behavior. A BDNF infusion into the PFC immediately after the last
cocaine self-administration session attenuated: (a) cocaine seeking upon re-exposure to
the se,1f-administration environment after 22 h or 6 days of abstinence; and (b) the
reinstatement of extinguished cocaine seeking produced by either CS presentation or a
cocaine-priming injection. In contrast, when BDNF was infused 6 days after the end of
chronic cocaine self-administration, it had no effect on cocaine seeking. These effects
were specific to cocaine-motivated behavior, as intra-PFC BDNF treatment failed to alter
food-seeking behavior in a fixed ratio 1 paradigm that directly paralleled the cocaineseeking experimental design in session length, contingent presentation of the CS and
reward availability. Furthermore, intra-PFC BDNF infusion blocked the suppressive
effect of cocaine self-administration on phospho-ERK and raised BDNF protein levels in
NAc, but not the caudate putamen, 22 h later. Together, these findings suggest that
BDNF infusion into the PFC has a selective suppressive effect on cocaine-seeking
behavior, possibly by increasing BDNF and normalizing phospho-ERK expression in the
NAc during early abstinence.
TrkB receptors are expressed by intemeurons and pyramidal neurons in the
cerebral cortex, but endogenous BDNF is expressed only by pyramidal neurons (Kokaia
et aI., 1993). However, BDNF and TrkB receptors are both found in postsynaptic
densities at asymmetric (excitatory) synapses in the cerebral cortex (Aoki et aI., 2000).
BDNF is anterogradely transported to excitatory terminals in the cerebral cortex and to
subcortical target structures including the striatum (Altar et aI., 1997), where it is released
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in a calcium-dependent manner (Hartmann et aI., 2001; Balkowiec & Katz, 2002; Pang et
aI., 2004).

Thus, it is likely that after an intra-PFC infusion, targeted in the dorsal

prelimbic cortex that has dense projections to the NAc (Vertes, 2004; Gabbott et aI.,
2005), exogenous BDNF binds to TrkB receptors, becomes internalized and is then
transported to the NAc, leading to elevated levels at 22 h. In support of this possibility,
exogenous BDNF is transported to remote sites in the CNS after intraventricular or
intracerebral infusion in monkeys (Mufson et aI., 1996). Additional evidence that
exogenous BDNF is internalized, transported and becomes available for activitydependent secretion has been demonstrated in primary hippocampal cultures (Santi et aI.,
2006). Furthermore, 22 h after infusion of BDNF into the mPFC of naive rats, BDNF
immunoreactivity is elevated in the NAc and amygdala, but not in the PFC or caudate
putamen, as compared with vehicle-infused rats (T.W. Whitfield, W.J. Berglind and IF.
McGinty, Appendix Figure 3). Thus, BDNF may have local effects at the site of infusion
(PFC) and distal effects in PFC-target areas like NAc. The possibility that exogenous
BDNF is transported to targets of PFC projection neurons will be directly investigated in
.future studies by infusing a fluorescently tagged BDNF (Stroh et aI., 2004) into the PFC
and searching for its presence in remote targets at different time points after infusion,
including the lateral hypothalamus and mediodorsal nucleus of the thalamus, which
receive the heaviest projections from the anterior cingulate and prelimbic cortex (Gabbott
et aI., 2005). BDNF has opposite effects on cortical pyramidal and interneuron excitatory
synapses

in

cortical

cultures:

it decreases

the

a-amino-3-hydroxy-5-methyl-4-

isoxazolepropionic acid quantal anlplitude of pyramidal neurons, whereas it increases the
AMP A quantal amplitude of interneurons (Rutherford et aI., 1998). This phenomenon
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requires several hours to develop in the presence of synaptic blockade and is known as
homeostatic plasticity or synaptic scaling (Turrigiano & Nelson, 2004). Thus, when
cortical activity is. high and BDNF release is increased, synaptic strengths are scaled to
promote decreased pyramidal neuronal activity and increased inhibitory interneuron
activity. Cocaine increases activity in cortico-accumbens projection neurons in animals
with a history of cocaine self-administration, resulting in acute increased extracellular
glutamate in NAc, even though animals with a cocaine history exhibit lower basal
glutamate levels (McFarland et ai., 2003). Thus, it is possible that elevated BDNF in the
cortico-accumbens pathway attenuates cocaine seeking by preventing this cocaineinduced glutamate overshoot or decreasing a cocaine withdrawal-induced increase in the
surface expression of AMP A receptors in the NAc (Boudreau et aI., 2007). However,
other mechanisms are possible, particularly because it is not known whether an increase
in glutamatergic transmission occurs in response to re-exposure of animals to a cocainepaired environment or in response to discrete CS presentation, similar to exposure of
animals to a cocaine challenge injection. Intra-PFC BDNF infusion immediately after the
last cocaine exposure, but not when delayed for 6 days, was effective in decreasing
cocaine seeking in abstinent rats and in rats that received explicit extinction training.
These effects of exogenous BDNF are different than its effects following infusion
into subcortical brain structures. For example, BDNF infused into the VTA or NAc
augments cocaine-induced sensitization (Horger et aI., 1999) and cocaine seeking
(Graham et ai., 2007; Lu et aI., 2004). Recent evidence indicates that synaptic
sensitization in midbrain dopamine neurons during protracted cocaine withdrawal is
BDNF- and N-methyl-d-aspartate (NMDA) receptor dependent (Pu et aI., 2006),
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implying that elevated BDNF in the VTA may contribute to synaptic potentiation that
may trigger drug seeking. Furthermore, infusion of BDNF in the NAc may augment the
effects of cocaine by directly stimulating TrkB receptors on medium spiny neurons
(Freeman et aI., 2003). In contrast, potentiation of glutamate signaling in the PFC, as
discussed above, may contribute to suppression of drug seeking by restoring homeostasis
to glutamatergic signaling, a hypothesis we propose to investigate. Interestingly, it is not
unprecedented that BDNF may have opposite effects in different brain regions: BDNF
infusion in the hippocampus has an antidepressant-like effect (Shirayama et aI., 2002),
whereas its infusion in the VTA has a depression-inducing-like effect (Eisch, 2003).
Therefore, as noted by Berton & Nestler (2006) with regard to antidepressant therapies,
proposing BDNF ligands as novel therapeutics for drug.addiction may be dependent on
developing BDNF signaling targets that differ in competing brain regions.
These data suggest that during early abstinence, BDNF interferes with cocaineinduced neuroadaptations that are critical to cocaine seeking. One adaptation reversed by
BDNF is a suppression ofNAc phospho-ERK expression in rats that were abstinent frOln
cocaine self-administration for 22 h and underwent an extinction test. This suppression of
phospho-ERK in the NAc of cocaine-seeking rats abstinent from cocaine selfadministration contrasts with recent evidence that cocaine-induced conditioned place
preference increases phospho-ERK in the NAc (Miller and Marshall, 2005). A major
difference between these cocaine-seeking paradigms that may underlie differential
phospho-ERK responses is that rats in the cocaine self-administration paired environment
press a lever previously associated explicitly with cocaine delivery, yet they do not
receive the drug reward. They are actively learning via instrumental responding in the
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first extinction test that cocaine is no longer available. The withholding of reward reduces
the strength of the CS and the contingent activation of midbrain dopamine and striatal
neurons (Tobler et ai., 2003; Schultz, 2007). As a consequence, extracellular dopamine
and glutamate levels, that are required for ERK activation in the NAc (Girault et ai.,
2007), would be predicted to fall. In contrast, rats re-exposed to the conditioned place
preference environment do not perform an instrumental task that teaches them that
cocaine is no longer available. Not surprisingly, extinction of conditioned place
preference is much slower to occur than extinction of self-administration behavior (Fuchs
et ai., 2002).
In conclusion, the prolonged effects of BDNF infusions on cocaIne seeking
behavior suggest that BDNF-based treatments may represent a novel approach to
preventing relapse. Further study of BDNF interactions with glutamate in the corticoaccumbens pathway should shed light on the mechanisms underlying the suppressive
effects ofintra-PFC BDNF infusion on relapse to cocaine seeking.
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CHAPTER 4

INTRA-PFC BDNF INFUSION NORMALIZES EXTRACELLULAR
GLUTAMATE LEVELS IN THE NAC FOLLOWING COCAINE SELFADMINISTRATION

Introduction
Relapse to drug-seeking during abstinence from cocaIne IS marked by
disturbances in glutamatergic neurotransmission in the PFC-NAc pathway in animal
models of addiction. Reinstatement of drug-, cue-, or context-induced cocaine-seeking is
blocked by the inactivation of the dPFC or NAc core by GABA agonists or the Na+
channel blocker, tetrodotoxin (McFarland and Kalivas 2001; Capriles et aI., 2003;
McFarland and See, 2003; Fuchs et aI., 2004; 2005).
AMP A

receptor

agonists

exacerbate,

and

Further, intra-NAc infusion of

antagonists

block,

cocaine-induced

reinstatement (Cornish and Kalivas, 2000) even when cocaine is delivered directly into
the PFC (Park et aI.., 2002). These inactivation studies support evidence from cocainewithdrawn animals that have long-term decreases in basal, and a sharp increase in
cocaine-evoked extracellular glutamate levels in NAc (Pierce et aI., 1996; Baker et al.,
2003). Two different mechanisms control basal and cocaine-evoked extracellular
glutamate levels: basal levels are Ca++ -independent and cystine/glutamate antiporter
(xCT)-dependent whereas cocaine-evoked levels are action potential and Ca++-dependent

(Pierce et aI., 1996; Baker et aI., 2003). After repeated cocaine exposure, diminished
xCT function can be reversed by administering N-acetylcysteine which normalizes basal
glutamate levels, stimulates presynaptic, inhibitory metabotropic glutamate 2/3 receptors,
preventing the cocaine prime-induced glutamate spike, and, consequently, suppresses
reinstatement of drug seeking (Baker et aI., 2003; Melendez et aI., 2005). The molecular
correlates that transform PFC-NAc synapses in response to cocaine remain to be
elucidated; however, there is convincing preliminary evidence that BDNF is a necessary
player.
BDNF activity is extensively associated with synaptic plasticity and associated
changes in receptor-mediated intracellular signaling. These events occur via a number of
BDNF activity-dependent mechanisms, all of which depend on the interaction of BDNF
with the TrkB receptor. Initially, BDNF can behave like a fast-acting neurotransmitter
and induces increased intracellular calcium release and modified ion channel activity
(Kafitz et ai., 1999). Neurotrophin-induced synaptic activation of Trk receptors results in
phosphorylation-depe"ndent internalization of the receptor-ligand complex that forms
intracellular signaling endosomes (Grimes et ai., 1996). The BDNF /TrkB dimer complex
can exert its effects within the post-synaptic scaffold by inducing the phosphorylation of
key intracellular signaling molecules., such as ERK, PI3K, and PLCy (Yuen and Mobely,
1999). The induction of these signaling molecules by TrkB receptor activation is well
documented and has been observed both in vivo and in vitro (Berhow et aI., 1996;
Cavanaugh et aI., 2001; Foulstone et aI., 1999; Fryer et aI., 2000; Matsumoto et aI., 2001;
Neal et aI., 2003). Furthermore, recent studies have demonstrated that infusion of antiBDNF into NAc prevented a cocaine-induced increase in phospho-PLeD (Graham et aI.,
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2007). Together, this evidence provides a strong correlation between BDNF activity,
TrkB receptor activation, and/or the activation of PLC 0, ERK, and PI3-kinase in
cocaine-associated behaviors. Finally, BDNF is able to exert long-term adaptations by
shifting transcription factor activation in favor of increased LTP and enhanced postsynaptic responses.. For example, BDNF increases the phosphorylation of transcription
factors, CREB and Elk-1, similar to effects observed following psychostimulants and
NMDA receptor stimulation in cortical and striatal neurons (Arthur et aI., 2004;
Finkbeiner et aI., 1997; Hardingham et aI., 1999; Simpson et aI. 1995; Valjent et aI. 2000).
Moreover, in vitro studies of mature cortical cultures have shown that BDNF induces
increases in the expression and translation of mRNAs that are associated with synaptic
functioning (Schratt et aI., 2004). Finally, exogenous application of BDNF enhances
glutamatergic transmission in the cerebral cortex by facilitating glutamate presynaptic
release as well as by enhancing AMP A receptor responsiveness (Lessmann 1998).
The role of exogenous BDNF in cocaine-associated behaviors and neuroadaptations has been demonstrated in the NAc. Intra-NAc BDNF potentiates cocaineinduced locomotor activity and lever-pressing during cocaine self-administration (Taylor
and Horger, 1999). Furthermore, intra-NAc BDNF during cocaine self-administration
increases cue and cocaine induced reinstatement and anti -BDNF decreases cocaineinduced reinstatement (Graham et aI., 2007). In contrast, we found that conditioned cueinduced or cocaine-induced reinstatement after two weeks of extinction is significantly
attenuated in rats that receive an infusion of BDNF into the PFC shortly after the last
cocaine self-administration session (Chapter 3 and Berglind et aI. 2007). Furthermore, an
intra-PFC BDNF infusion prevented a decrease in phospho-ERK expression in the NAc
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that normally occurs after 22 h of abstinence from cocaine self-administration (Chapter 3
and Berglind et aI, 2007).

This evidence suggests that intra-PFC BDNF suppresses

reinstatement behavior by altering cocaine-induced neuroadaptations in the PFC-NAc
pathway. The present study examined the effects of intra-PFC BDNF infusions on basal
and cocaine-induced extracellular glutamate levels in the NAc in rats with a cocaine selfadministration history.

Materials and Methods
Animals
Male Sprague-Dawley rats (N=60; Charles River), weighing 275-325 grams at the
time of surgery, were housed individually on a reverse light/dark cycle.

Rats were

maintained on 20-25 g of rat chow per day, with water available ad libitum. All protocols
were approved by the Institutional Animal Care and Use Committee of the Medical
University of South Carolina and carried out in accordance with the National Institutes of
Health Guide for the Care and Use of Laboratory Animals (NIH Publications No.

80-23~

revised 1996).

Lever Response Training
Rats were trained to lever press on a fixed ratio 1 schedule of food reinforcement
(45 mg pellets; Noyes, Lancaster, NH) in sound-attenuated operant conditioning
chambers (30 x 20 x 24 cm high; Med Associates Inc., St. Albans, VT) during a 16 h
overnight training session. The chambers were equipped with two retractable levers, a
stimulus light above each lever, a food pellet dispenser between the levers, a house light
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on the wall opposite the levers, and a speaker connected to a tone generator (ANL-926,
Med Associates Inc, St. Albans, VT). During the session, each lever press on the active
lever resulted in delivery of a food pellet only. Lever presses on the inactive lever had no
programmed consequences.

Following food training, food pellet dispensers were

removed from the chambers.

Surgery

Forty-eight h after food training, rats were anesthetized with a mixture of
ketamine hydrochloride (66 mg/kg i.p.; Fort Dodge Animal Health, Fort Dodge, IA) and
xylazine (1.33 mg/kg i.p.; Bayer, Shawnee Mission, KS) followed by Equithesin (0.5
ml/kg, i.p.). Catheters constructed of Silastic laboratory tubing (0.64 mm i.d., 1.19 mm
o.d.; Dow Coming, Midland, Mich.) were implanted into the rig~tjugular vein of rats and
were anchored to the vein with silk suture and a hardened silicon gel ball (silicon rubber
sealant; General Electric, Waterford, N.Y.) placed 33 mm from the anterior end of the
catheter. The Silastic tubing ran directly under the skin to an exit point located in the
mid-scapular region. The open end of the catheter was enclosed with a short piece of
polyethylene tubing that had been heat-sealed and the threaded region of the catheter was
covered with a threaded plastic cap when not in use. Immediately following catheter
implantation, rats were mounted onto a stereotaxic device (Stoelting, Wood

Dale~

Ill.)

and bilateral stainless steel cannulae (26 gauge, Plastics One Inc., Roanoke, VA) were
implanted 1 mm above the PFC target region (AP= +3.0; ML= +0.6; DV= -1.6, relative
to bregma, Paxinos and Watson, 1998).

Following implantation, the mPFC guide

cannulae were briefly secured to the skull with a small amount of super glue. Bilateral
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stainless

st~el

cannulae (20 gauge, Plastics One Inc.) were implanted 2 mm above the

NAc target region (AP=2.5; ML=0.6 6°, relative to bregma, Paxinos and Watson, 1998).
Following implantation of the dialysis guide cannulae, cranioplastic cement anchored by
three steel machine screws was applied to permanently secure the mPFC and NAc
cannulae to the scull. Stylets (Plastics One, Inc.) were placed into the guide cannulae to
prevent blockage. Following surgery, rats were infused i.v. with 0.1 ml each of cefazolin
(100 mg/ml) and heparinized saline (70 V/ml) once daily during a 5 day recovery period.
Catheter patency was verified by infusing 0.1 ml of methohexital sodium (20 mg/ml, i.v.;
. Eli Lilly and Co., Indianapolis, IN), which produces a rapid loss of muscle tone only
when administered intravenously.

Cocaine Self-administration
Cocaine self-administration was conducted in standard self-administration operant
chambers (30 x 20 x 24 cm; Med Associates, 8t Albans, VT). Each chamber contained
two retractable levers (7 cm above the chamber floor) on each side of the front wall. A
white circular stimulus light (2.5 W, 24-V bulb) was located on the panel 7 cm above the
active (right) lever, and a red house light (2.5 W, 24-V bulb) was located on the \vall on
the opposite end of the chamber.

The infusion line was tethered to a liquid swivel

(Instech, Plymouth Meeting, P A) mounted on a suspended counterbalance. The selfadministration apparatus was enclosed in a sound-attenuating chamber (Med Associates).
Cocaine hydrochloride (4 mg/ml; National Institute on Drug Abuse/ RTI International,
Research Triangle Park, NC) was delivered using a computer-controlled infusion pump
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located outside the chamber. The entire system was computer controlled using Med PC
for Windows.
Rats self-administered cocaine on 10 consecutive days during 2 h daily sessions.
Figure 1 illustrates the experimental design of each of the experiments. Rats received 0.1
ml of heparinized saline (IOUIml, i. v.) prior to each self-administration session.
Animals were then connected to the infusion tether and each session began immediately,
signaled by the movement of both levers into the chamber. Cocaine reinforcement was
available, on a FRI schedule of reinforcement explicitly paired with a compound
conditioned stimulus (CS) consisting of illumination of a white stimulus light located
above the active lever and a tone (2 kHz, 15 dB above ambient noise). Responses on the
active (right) lever resulted in the delivery of cocaine (0.2 mg/0.05 ml bolus) over 2 sec,
and each infusion was followed by a 20 sec 'time-out' period. During the time-out,
active lever presses were recorded, hut had no programmed consequences. Responses on
the inactive (left) lever were also recorded, but had no programmed consequences.
Yoked-saline rats (experiment I-see below) received an infusion of saline (0.05 ml bolus)
over 2 sec, contingent upon the cocaine infusion received by the self-administering rat in
Rats underwent 10 days of cocaine self-

the adjacent self-administration chamber.

administration prior to a single intracranial infusion.

Abstinence, extinction, and reinstatement
Figure 4-1 illustrates the experimental design for experiments one and two during
which rats self-administered cocaine for 10 days. Immediately following the final selfadministration session, rats in both experiments received an intra-PFC infusion of either

72

BDNF (0.75 Jlg/flllside) or vehicle (1 JlI).

Following

self-administration

rats

In

experiment 1 underwent 10 days of extinction training, during which lever presses had no
programmed consequences. Following extinction, rats in experiment one underwent a
single 2 h cocaine prime-induced reinstatement test for which each rat was injected with
cocaine (10 mg/kg, i.p.) at the beginning of the test.

During the cocaine-primed

reinstatement test, lever presses were recorded, but had no programmed consequences.
Following the cocaine prime-induced reinstatement test, rats in experiment one
underwent 7-10 further days of extinction training before undergoing glutamate microdialysis, during which glutamate extracellular levels within the NAc were evaluated
before and after a cocaine prime (10 mg/kg, Lp.). Rats in experiment two differed from
those in experiment one in that they underwent 14 days of extinction training before their
first dialysis day, and a further 7 days of extinction training before their second day of
dialysis performed in the contralateral hemisphere.
performed during both dialysis days in experiment two.
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No-net flux micro-dialysis was
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Fig. 4-1. Schematic diagram of the experimental paradigm used.

mPFC Intracranial Infusions
We adopted a single infusion protocol and chose a dose of BDNF (0.75 flg/side)
previously used in vivo (Lu et aI., 2004; Berglind et aI., 2007) .. For BDNF or vehicle (10
mM PBS) infusions, infusion cannulae (33 gauge; Plastics One Inc.) were inserted
bilaterally into the guide cannulae such that 1 mm of the infusion cannulae extended past
the end of the guide cannulae.

Human recombinant BDNF (R&D Systems, Inc,

Minneapolis, MN) or vehicle (sterile phosphate buffered saline) was infused using gastight Hamilton syringes (10 fll) and an infusion pump (Harvard Apparatus, Holliston,
MA). A volume of 0.5 fll was infused over 2 min and the infusion cannulae remained in
the guide cannulae for one min before and after the infusion.
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Glutamate microdialysis

Micro-dialysis probes were constructed utilizing fused silica for inlet and outlet
tubing into 26-gauge cannulae topped with a semi-permeable membrane with 2 mm of
active length. On the evening before the sample collection, subjects were housed in the
operant chamber and probes were inserted into the NAc via previously implanted 20gauge cannulae. Dialysis buffer (5 mM glucose, 2.5 mM Kcl, 140 mM NaCI, 1.4 mM
CaCh, 1.2 mM MgCh and 0.15 % PBS, pH 7.4) was perfused through the probe
overnight at 0.2 J.lI/min. In the morning, the flow rate was increased to 2.0 J.lI/min for 2 h.
Each rat then received an i.p. injection of cocaine (10 mg/kg), following which, samples
were collected every ten minutes for an additional 2 h. All samples were collected into
10 J.lI of 0.05 M HC!.

Samples were then stored at -80°C for future analysis of

extracellular glutamate (see below).

No-net-flux microdialysis

No-net-flux micro-dialysis was performed in the same manner as described above.
However, following collection of baseline samples for 2 h, the no-net-flux procedure
began by changing the perfusate to dialysis buffer containing 2.5, 5, or 10 IlM glutamate.
Liquid switches were used to minimize the pressure fluctuations while changing dialysis
buffers with varying concentrations of glutamate. Six samples were collected at 10 min
intervals for each concentration.
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Analalysis and quantification of extracellular glutamate
We analyzed glutamate levels from the NAc using high performance liquid
chromatography (HPLC) as described previously (Bell et ai., 2000).

Samples were

loaded on an autosampler (Gilson Medical Electric, Middleton, WI) that derivatized the
sample with o-pthalaldehyde prior to injecting it into the column via circulating mobile
phase (100 mM sodium dihydrogen phosphate monobasic, 90 M EDTA-N(4, and 15%
acetonitrile v/v, pH 6.04). Amino acid separation was done using a reversed-phase CI8
(15 cm) column.

A florescence spectrophotometer (RF-IOA-Shimadzu) detected

glutamate concentrations using an excitation wavelength of 340 run and an emission
wavelength of 455 run.

A chart recorder recorded the peaks and peak heights were

measured manually and quantified using external glutamate standard curves as described
(Melendez et aI., 2005).

Results
Histology
Subjects with cannulae tracts that failed to fall within the selected criteria for
mPFC for infusion cannulae or NAc for dialysis cannulae placement were excluded from
the schematic and the subjects' data was excluded from the data analysis (n=4).

76

+ .60mm

+1.l0mm

+ 1.001

m

Figure 4-2: Cannula Placement. A schematic representation of the active length of the
dialysis membrane within the NAc (A) and the tip of the infusion cannulae within the
PFC (B)

Self-administration, extinction, and reinstatement
All rats exhibited stable active (right) lever responding over the last three days of
self-administration that did not differ between groups (Fig 4-3). An ANOV A revealed no
effect of treatment on active lever pressing over the last three days of self-administration
(Fl ,18=0.034; p>0.05).

Furthermore there was no significant effect of treatment on

inactive lever-pressing over the last three days of self-administration (F 1,18=1.03; p>0.05).
All rats underwent extinction training until criterion (less than 25 active lever presses per
day).

There was a significant effect of intra-PFC BDNF treatment on active lever

responding during the first day of extinction ((F 1,18=3.434; p<0.05), but not inactive
lever-pressing ((F} ,}8=0.001; p>0.05). However, there was no effect of intra-PFC BDNF
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treatment on active lever-pressing (F 1,18=0.009; p>0.05), or inactive lever-pressing
(F 1,18=0.056; p>0.05)

during the last two days of extinction training pnor to

reinstatement testing .
All rats in experiment one underwent a single cocaine-induced reinstatement
sessIon.

An ANOV A revealed a significant effect of intra-PFC BDNF treatment on

active lever-pressing during the 2 h reinstatement test ((F 1,12=10.66; p<0.05), but not on
inactive lever-pressing (F 1,12=2.995; p>0.05).
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Figure 4-3: Behavior Effects of Intra-PFC BDNF. Effects of intra-PFC BDNF
infusion on self-administration, extinction, and cocaine-prime induced reinstatement.

Experiment 1
Intra-PFC BNDF blocked a cocaine prime-induced increase in extracellular levels
of glutamate within the NAc
Following extinction training, each rat in experiment one underwent mIcrodialysis procedures to evaluate extracellular glutamate levels within the NAc before and
after a single cocaine prime (10 mgikg, i.p.). Basal and cocaine-induced glutamate levels
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were measured for two h at 10 min intervals.

Statistical analysis was determined by

evaluating the area under the curve (AUC) for each group during the 2 h basal samples
and for the 2 h following the cocaine prime.

An ANOV A revealed a significant

interaction of group X time (Fl ,18=4.798; p<O.Ol).

A Tukey's HSD test revealed a

significant effect of intra-PFC BDNF treatment on the AUC following the cocaine prime
(p=O.013), but not during baseline collection (p=O.77). Furthermore, a Tukey's HSD test
revealed a significant effect of the cocaine prime itself as compared to baseline in the
vehicle-treated group (p=O.Oll) but not in the BDNF-treated group (p=O.969).
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Figure 4-4: Effect of intra-PFC BDNF on evoked extracellular glutamate within the
NAc Effect on intra-PFC BDNF, administered after the last cocaine self-administration
session, on extracellular glutamate levels before and after a single cocaine challenge (10
mg/kg, i.p.) in rats with a cocaine self-administration history. Rats that received intraPFC infusions of BDNF exhibited a suppression of the increase in glutamate observed in
the rats that received intra-PFC vehicle infusions. *, p<O.05 AUC of BDNF animals
following cocaine prime vs. AUC of vehicle-treated animals following cocaine prime ; #,
p<O.05 , vehicle-treated baseline vs. vehicle-treated following cocaine-prime.
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Experiment 2
Intra-PFC BDNF normalized basal levels of extracellular glutamate within the NAc
Figure 4-5 illustrates the gain or loss of glutamate as a function of the
concentration of glutamate added to the perfusate (Lonnroth et aI., 1987). A positive
number on the y-axis is indicative of a net diffusion of glutamate into the brain and a
negative number indicates a net diffusion from the brain to the collected perfusate. The
y-axis intercept is indicative of the basal extracellular glutamate concentration within the
NAc for each group. The slope of each line indicates the in VIvo recovery in each group.
Using linear regression analysis, the stope was not significantly different between groups
(F 1,14=1.34, p>0.05).

However, rats that received intra-PFC BDNF treatment

demonstrated a significant difference in the y-intercept (F 1,14=5.693, p<0.05), indicating
that BDNF -treated rats had significantly higher basal extracellular glutamate levels
within the NAc as compared to vehicle-treated rats.

Also, the value of glutamate

measured coming out was significantly different for each concentration of glutamate
added to the perfusate in BDNF-treated rats as compared to vehicle-treated rats (0 JlMF 1,14=5.44, p<0.05; 2.5 JlM- F 1,14=7.711, p<0.05; 5.0 JlM, p<0.05; 10 JlM- FL 14=13.78,
p<0.05).
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Figure 4-6: Point of No-Net Flux. The zero points on the y-axis of figure 4-5 indicate
the steady state at which there is no net flux of glutamate across the dialysis membrane
and provides a measure of the basal extracellular glutamate concentration. Intra-PFC
BDNF treatment significantly increased the zero point, indicating an increase in the basal
extracellular glutamate concentrations in the rats compared with those that received intraPFC vehicle infusions (*p<O.05).

Discussion
In the present study, an intra-PFC infusion of BDNF produced a significant
alteration in both the basal and cocaine prime-evoked levels of extracellular glutamate in
the NAc of rats with a cocaine self-administration history. Specifically, when BDNF was
infused into the mPFC immediately after the final cocaine self-administration session,
basal levels of glutamate within the NAc were greater after 2-3 weeks of extinction
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Ca++ stores, in cultured cortical neurons (Matsumoto et aI., 2001). Alternatively, BDNF
may interact with xCT in an unknown manner to restore non-synaptically derived
extracellular glutamate. However, a direct interaction between anterogradely transported
BDNF in PFC-NAc neurons and xCT expressed by local glia in the NAc is somewhat
implausible. Further studies in which Ca++ is inhibited or xCT and mGluR2/3 receptors
are blocked (Moran et aI., 2005) or glutamate uptake is measured may help determine the
mechanism by which BDNF restores basal extracellular glutamate levels and prevents a
cocaine-prime-induced increase in glutamate in the NAc.
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CHAPTERS

SUMMARY, DISCUSSION, AND FUTURE DIRECTIONS

Summary and Significance
In the present body of work, BDNF mRNA expression within the PFC was
significantly decreased following 22 h of abstinence from repeated cocaine selfadministration. This decrease in BDNF mRNA expression was not present following 21
d of abstinence from repeated cocaine self-administration but a significant increase in
BDNF protein was observed at this time-point.

These data indicate that BDNF

expression within the PFC shifts from a relatively modest mRNA reduction in early
abstinence to a more pronounced elevation following extended abstinence. This increase
in endogenous BDNF that occurs gradually over the duration of abstinence Inay
contribute to the propensity to relapse into drug-seeking behavior. However, exogenous
BDNF administered into the PFC immediately following the final cocaine selfadministration session attenuated relapse to cocaine-seeking following re-exposure to
cocaine-associated contexts, cues, and cocaine itself up to 3 weeks later. Furthermore, 22
h following repeated cocaine self-administration, a decrease in pERK expression within
the NAc was prevented and extinction responding was attenuated by intra-PFC BDNF

treatment. After more extensive withdrawal in rats whose active lever pressing behavior
was extinguished, intra-PFC BDNF treatment prevented a cocaine-induced increase in
extracellular glutamate within the NAc.

Moreover, a decrease in basal extracellular

glutamate levels induced by repeated cocaine self-administration was normalized by
intra-PFC BDNF administration.
The findings of this study are novel and significant for several reasons. First, the
enduring effects of a single intra-PFC BNDF infusion on drug-seeking behavior
following extended abstinence are unique and have therapeutic significance. The fact that
a single infusion of BDNF is able to alter cocaine-seeking behavior in a consistent
manner over different durations of withdrawal is remarkable considering the possible
therapeutic value of such an extended duration of activity following a single treatment.
Second, intra-PFC BDNF infusions significantly reduced lever-pressing previously
associated with cocaine availability following re-exposure to multiple stimuli, including
context, cues, and a cocaine prime, at every time-point of withdrawal tested. Third, the
critical timing of the intra-PFC BNDF infusion (immediately following the last cocaine
exposure) represents a "therapeutic window" during which BDNF is able to reduce drugseeking behavior. Fourth, the ability of intra-PFC BDNF to restore phospho-protein
expression and glutamatergic transmission in the NAc suggests that exogenous BDNF is
taken up and transported throughout PFC-NAc neurons, in contrast to drugs that act only
in the local extracellular environment in which they are infused. Finally, the effects of
intra-PFC BDNF infusions on drug-seeking behavior are the opposite of those described
in previous reports in which BDNF was infused into the VTA or NAc respectively (See
Table 5-1 for summary; Lu et at, 2004; Graham et at, 2007). This striking difference in
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behavioral effects demonstrates the diverse actions of exogenous BDNF in different brain
regions and its ability to restore glutamatergic transmission in the PFC-NAc pathway that
is distorted by chronic cocaine.

PFC
(PRESENT STUDY)

Effect of
Cocaine SA
On
Endogenous
BDNF

Early
withdrawal

Late
withdrawal

Protein
Expression

------------ ---------- ----------------------------------------

mRNA
Expression

Decreased

Protein
Expression

Increased

----~-~------~~--~-~ -~

mRNA
Expression

Early withdrawal

Effect of
Exogenous
BDNF
Following
Cocaine SA

No change

VTA

No change

No change

(Grimm et al.,2003)

(Grimm et al.,2003)

------------------------------------

-

N/A

N/A

Increased

Increased

(Grimm et al.,2003)

(Grimm et al.,2003

----------------------------------------

-- ... ----------- .... ------ ..... --------------

No change

N/A

N/A

Attenuates extinction
responding

Increases
extinction
responding

N/A

Increases pERK
expression in NAc

Late withdrawal

NAc

Attenuates
reinstatement
responding
Prevents cocaineinduced changes in
NAc extracellular
glutamate

.

(Graham et aI., 2007)

Increases cue
and cocaineinduced
reinstatement

Increases
Cue/Contextual
Reinstatement
(Lu et al., 2004)

(Graham et aI., 2007)

Table 5-1: Summary of studies examining the changes in BDNF expression induced by
cocaine self-administration and the effect of exogenous BDNF.
Together these findings stress the distinctiveness of the effect of intra-PFC BDNF
on cocaine-induced drug-seeking and on the cocaine-induced neuroadaptations in the
PFC-NAc pathway. Considering the scope of this body of work, the variety of protocols
employed, and the novelty of the findings there is little corroborating evidence to guide
the mechanistic interpretation of the findings. However, integrating what is known about
the properties of the PFC-NAc pathway following chronic cocaine, the role of BDNF
within the NAc-PFC pathway, and the neuroadaptations driving the propensity to relapse,
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a plausible explanation of the observed findings can be offered. Two central questions
frame the discussion of the mechanisms underlying the behavioral effects of intra-PFC
BDNF:
1. What effect does exogenous BDNF have on the local cortical circuitry?
2. How does intra-PFC BDNF prevent cocaine-induced neuroadaptations in the NAc?

BDNF Regulates Homeostasis via Synaptic-Scaling Mechanisms in the PFC

Figure 6-1 illustrates the local circuitry within the prefrontal cortex that is
characterized by recurrent

connections between GABAergic

interneurons and

glutamatergic pyramidal neurons. Endogenous BDNF is uniquely suited to regulate PFC
activity for several reasons. First, BDNF is produced by cortical pyramidal neurons and
BDNF mRNA expression is present in significant amounts throughout the cortex with the
exception of the agranular layer (Altar et aI., 1997). Activity-dependent release of BDNF
stimulates TrkB receptors located both pre-and post-synaptically on cortical pyramidal
neurons and intemeurons (Cabelli et aI., 1996). Additionally, BDNF has been shown to
induce glutamate release from cortical astrocytes and pyramidal cells (Pascual et ai.,
2001).

Finally, BDNF signaling is able to alter long-term neuroadaptations by altering

gene expression within post-synaptic neurons (Watson et aI., 1999).
In addition to these cellular mechanisms of action, BDNF also regulates global
PFC activity and modulates PFC homeostasis.

For example, in response to major

increases in input by decreasing the quantal amplitude of AMP A-mediated excitation on
pyramidal neurons and enhancing the GABAergic inhibitory amplitude at excitatory
synapses, contributing to the homeostatic regulation of inhibitory vs. excitatory synaptic
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strength within this circuitry (Rutherford et aI., 1998; Turrigiano and Nelson 2004).
However, when cortical activity is depressed over extended periods of time and BDNF
expression is reduced increased sensitivity of pyramidal cells to excitatory input leads to
abnormal hyperactivity. This scenario is extremely provocative considering that repeated
cocaine induces a disruption in the homeostatic imbalance within the PFC (Trantham et
aI., 2002; Sun and Rebec 2006).
withdrawal, there are

Specifically, in the absence of cocaine during

increases in inhibitory neurotransmission within the PFC and

decreases in basal pyramidal cell activity (Jayaram and Steketee, 2005; Nasif et aI. 2005;
Jayaram and Steketee, 2006).

However, this is contrasted by the fact that the

responsiveness of the PFC to excitatory inputs is greatly enhanced by increases in GluR
sensitivity and increased propensity for LTP (Dong et aI., 2005; Hu, 2007; Huang et ai.
2007).

Glu BDNFmRJ

Figure 6-1: Recurrent connections between glutamatergic pyramidal neurons and
GABAergic interneurons that express TrkB receptors within the cerebral cortex. BDNF
regulates the synaptic strength of pyramidal neurons and interneurons in response to
strong stimuli to maintain homeostatic control of PFC activity. The level of excitation
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and resultant firing is carefully stabilized by the interaction of these two cortical neuronal
subtypes. At the synaptic level, increases and decreases in quantal release, known as
quantal scaling, have been hypothesized to underlie synaptic plasticity in the cerebral
cortex. BDNF signaling within the cortex is thought to drive synaptic scaling (Adapted
from Rutherford et aI., 1998).

Exogenous BDNF restores PFC homeostasis withdrawal from cocaine selfadministration

In the present study, a significant decrease in BDNF mRNA expression within the
PFC was observed during early withdrawal, which is evidence of suppressed PFC activity.
Furthermore, a decrease in basal, and an increase in evoked, glutamate within the NAc
was demonstrated similar to the findings of McFarland et al (2003), re-emphasizing that
cocaine decreases basal, and enhances cocaine-induced, glutamatergic transmission.
However, rats that received intra-PFC BDNF treatment did not exhibit either the decrease
in basal glutamate levels or an increase in glutamate levels following a cocaine priming
injection. This evidence suggests that intra-PFC BDNF is able to stabilize the cocaineinduced depression in PFC activity and restore the imbalance in PFC homeostasis. The
mechanisms that drive the restoration of PFC-NAc neurotransmission by BDNF may
involve the unique homeostatic role that BDNF has demonstrated within the cerebral
\

cortex.
In the present study exogenous BDNF was infused within the PFC within 20
minutes of the end of the last cocaine self-administration session. It is likely that a
permissive state of the PFC existed at the time BDNF was infused that led to enduring
behavioral and molecular changes. There is some evidence that there is a transient
increase in extracellular glutamate within the PFC following repeated cocaine (Williams
and Steketee, 2004).

Also, a recent study demonstrates that extracellular levels of
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glutamate within the NAc are increased during the self-administration session; however,
the greatest increases were observed during the 40 minutes immediately following the
end of the self-administration ses'sion (Miguens et aI., 2007). This report suggests that
cocaine-induced glutamatergic transmission in the PFC activity peaks at the same time
that BDNF is infused in our study. The synergistic effect of BDNF infusion and cocaineinduced pyramidal cell firing may be sufficient to restore the homeostatic balance within
the cortical networks. Therefore the effect of exogenous BDNF to prevent reinstatement
behavior may endure long after the acute effects of the injection by initiating changes in
the PFC homeostatic set point, an effect that could persist and account for the long-term
effects of an intra-PFC BDNF infusion. As BDNF is restoring regulatory control over
PFC activity, it may also have trans-synaptic effects within the NAc that are also
important in reversing the cocaine-induced neuroadaptations that drive drug-seeking.
Effects of intra-PFC BDNF within the Striatum
Summary

Many of the long-term neuroadaptations induced by chronic exposure to cocaine
have been observed within the NAc. These included multiple alterations in presynaptic
and postsynaptic dopamine and glutamate signaling (Vanderschuren and Kalivas" 2000;
Cornish and Kalivas, 2001; Hemby et aI., 2005; Boudreau et aI., 2007). Modifications of
dopaminergic synapses have a common thread in that most are associated with increased
sensitivity of molecules associated with dopamine signaling. For example, D1 dopamine
receptors remain supersensitive in response to electrophysiological stimulation
throughout withdrawal (Henry and White, 1991). Additionally, there is an increase in the
releasability of pre-synaptic dopamine stores, dependent upon calciumlcalmodulin-
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dependent protein kinase II activation (Pierce and Kalivas, 1997). These and other longlasting changes in dopamine signaling may contribute to the overall role of the NAc on
reinstatement to cocaine-seeking behavior but presently there is no clear evidence of a
essential association between reinstatement behavior and alterations in dopamine neurotransmission. This may be due to the compulsory nature of the dopamine response to
cocaine, which remains unchanged regardless of prior drug history or duration of
withdrawal (McFarland et aI., 2003).
The role of glutamate signaling within the NAc on cocaine-induced
neuroadaptations and drug -seeking is critical.

Many of the enduring changes in

glutamate transmission generally follow a common pattern of basal depression contrasted
by an exaggerated response to cocaine-related stimulation.

This includes decreased

basal extracellular glutamate and enhancement of glutamate levels following a cocaine
challenge (Pierce et aI., 1996; McFarland et aI., 2003; Miguens et aI., 2007).

The

decreased basal glutamate neurotransmission has been associated with reduced activity of
the cystine-glutamate exchanger, a passive exchanger driven by concentration gradient
and located on glial cells within the NAc (Baker et aI., 2003). Furthermore, it has been
suggested that the enduring decreases in basal glutamate decrease the tone on presynaptic
mGluRs, inhibitory autoreceptors, which allow for increased glutamate release following
re-exposure to cocaine (Xi et aI., 2004; Melendez et AI, 2005; Moran et aI., 2005).
Little is known about the role of BDNF in the long-term effects of cocaine within
the NAc. It is known that NAc BDNF expression is largely derived from glutamatergic
pyramidal cells (Altar et aI., 1997). Additionally, BDNF protein expression is increased
progressively following extended durations of abstinence and this has lead to suggestions
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that BDNF plays a role in the incubation of craving phenomenon (Grimm et aI., 2003).
However, it remains unknown if the increase in BDNF protein expression is presynaptic
and/or postsynaptic and what neuronal sub-type(s) within the NAc is harboring it. While
the role of endogenous BDNF activity on cocaine-induced NAc neuroadapatations
remains unclear, exogenous BDNF within the NAc consistently produces increases in
cocaine-associated behaviors (Horger et aI., 1999; Graham et aI., 2007).
In the present study, intra-PFC BDNF prevented cocaine-induced reductions in
phospho-ERK within the NAc during early withdrawal.

Further, intra-PFC BDNF

prevented cocaine-induced reductions in basal glutamate and the enhanced release of
glutamate upon re-exposure to cocaine after extended withdrawal. Additionally,
considering that increased BDNF protein expression was observed within the NAc 22 h
after an intra-PFC BNDF infusion in preliminary studies (see Appendix Figure 3), it is
very likely that BDNF infused into the PFC is anterogradely transported to the NAc
where it is expressed within 22 h. BDNF is anterogradely transported in large dense core
vesicles via microtubule-based motor proteins, likely kinesin-l (Butowt and Bartheld,
2007). ,and released in an activity-dependent manner (Matsumoto et aI., 2008). Studies
have demonstrated that this type of transport operates at approximately 250mmlday
(I-Iirokawa, 1998). This would allow ample time for BDNF that has been infused into the
PFC to be transported and have local effects within the NAc. This assumption, once
...

confirmed, can be exploited in future studies to delineate the precise mechanisms that are
underlying cocaine-seeking behavior. Either intra-PFC BDNF is fundamentally altering
local PFC activity as discussed above and this is sufficient to drive all of the behavioral
effects and trans-synaptic molecular changes or BDNF is anterogradely transported in
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PFC-NAc neurons and is synaptically released in an activity-dependent manner into the
NAc milieu. The possible effects of synaptic BDNF release within the NAc after intraPFC infusion on cocaine-associated phospho-ERK and glutamate transmission are
discussed below.

PFC-NAc BDNF Transmission: Pre-Synaptic Activity
Extracellular glutamate levels within the NAc were normalized in rats that
received intra-PFC BDNF immediately following the final cocaine self-administration
session. Although this effect is may involve increased pyramidal cell activity from the
PFC, the effect ofBDNF on pre-synaptic glutamate release at the level of the NAc should
not be overlooked.

BDNF has been shown to induce increases in both glutamate and

dopamine release from pre-synaptic stores, an effect that was diminished by TTX and
low calcium and was dependent upon TrB signaling (Paredes et aI., 2007).

TrkB

receptors, located pre-synaptically within the NAc, may be activated by released BDNF
and alter the pre-synaptic machinery associated with neurotransmitter release. In
particular, BDNF-induced stimulation of pre-synaptic TrkB receptors induces activation
of ERK MAPK that leads to the enhanced phosphorylation of synapsin in cortical
synaptosomes (Jovanovic et aI., 2000). An increase in activated synapsin is responsible
for trafficking synaptic vesicles from a reserve pool to a stand-by-ready pool that is
released by exocytosis.

In this scenario, BDNF would be anterogradely transported to

the NAc, released from pyramidal cell terminals, bind and activate pre-synaptic TrkB
receptors, initiate the cascade that leads to the phosphorylation of ERK, that in tum
activates synapsin, allowing the phosphorylated synapsin to increase vesicular release by
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upgrading the vesicle from "soon" to "next", and finally the ready pool is released in an
activity-dependent manner. Considering that the activity of synapsin is ERK-dependent
and a decrease in phospho-ERK expression occurred after cocaine self-administration,
there is a positive correlation with a reduction in glutamate release from the pre-synaptic
terminal of cocaine self-administering rats.

In rats that received intra-PFC BDNF

treatment, the decrease in phospho-ERK and extracellular glutamate changes within the
NAc were prevented. Therefore, it is likely that BDNF exerts its effects within the NAc
by altering presynaptic glutamate release in early abstinence, a hypothesis that needs to
be tested. Additionally, it is unlikely that BDNF anterogradely transported to the NAc
from the PFC would affect DA release within the NAc considering pyramidal neurons do
not directly synapse with dopaminergic neurons. Furthermore, considering the proximal
association of the DA efferents with MSN s within the striatum, it is unlikely that BDNF
arising from the cortex would ever interact with presynaptic DA terminals or illicit DA
release within the NAc. Interestingly, this may contribute to the behavioral differences
observed when BDNF is infused into the cortex and is transported via a glutamatergic
pathway to the NAc rather than infused directly into the NAc or via the VTA
dopaminergic pathway, both of which could potentially increase DA release in the NAc.
Therefore, consideration that BDNF is released from PFC-NAc terminals after infusion
and activates postsynaptic TrkB receptors on medium spiny neurons (Freeman et aI.,
2003) to promote the restoration of glutamatergic-driven plasticity is discussed below.

Trans-synaptic BDNF can alter post-synaptic activity
BDNF has been shown to evoke rapid post-synaptic excitation by increased ion
channel activation in several brain areas including the cortex (Kafitz et ai. 1999, Rose et
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aI., 2000). BDNF also binds to post-synaptic TrkB receptors and initiates several kinase
cascades that have multiple post-synaptic effects, such as CREB phosphorylation (Marini
et aI., 2004; Wu et aI., 2004). Also, BDNF induces alterations in the post-synaptic
neuron that increase the synaptic efficacy of AMP A receptors (Lessmann 1998).
Therefore, it is possible that the cocaine-induced decrease in phospho-ERK expression
within the NAc following 22 h of withdrawal was postsynaptic and prevented by synaptic
release of BDNF and stimulation of TrkB receptors in the NAc after intra-PFC BDNF
treatment. However, a post-synaptic action of BDNF in the NAc is made less likely by
the opposite (enhanced) cocaine-seeking effects of BDNF infused directly into the NAc
in cocaine self-administering rats (Graham et aI., 2007).

Future Directions
Because the mechanisms that underlie the suppressive effect of intra-PFC BDNF
infusions on cocaine-seeking behavior are not yet known, future directions should focus
on identifying the site and mechanisms of action of BDNF's effects. It may be that
BDNF in the PFC acts locally on TrkB receptors and alters the activation state of
plasticity-related intracellular signaling cascades, including PI3K PLC, and/or MAPK,
driving intra-PFC BDNF effects on attenuation of drug-seeking behavior. Using selective
inhibitors of Trk receptors, MEK and PI3K in the PFC, the experiments that will attempt
to answer these questions would be executed as follows:
1) Infuse the selective Trk inhibitor, K252a, the MEK inhibitor (UO 126) or the selective
PI3K inhibitor (L Y294002) into either the PFC or NAc along with BDNF to determine
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the site of action of BDNF and the role of those individual BDNF -associated intracellular
signaling cascades on the intra-PFC BDNF-induced suppression of cocaine-seeking
behavior.
2) Utilize fluorescently-tagged exogenous BDNF infused into the PFC and measure
fluorescence levels in afferent targets of the PFC after different time-points. This would
help to determine the spread of BDNF and help to elucidate the site of action of BDNF
and its effects on reinstatement behavior.
3) Determine the effect of intra-PFC BDNF infusions on the electrophysiological
characteristics of pyramidal cells that project to the NAc.

This would include

determining what changes if any exist in firing rates or changes in burst firing.
4) Determine whether the ability ofintra-PFC BDNF to normalize extracellular glutamate
levels in the NAc occurs during early withdrawal and is Ca++-dependent or not.
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APPENDIX 1: EFFECTS OF INTRA-VTA BDNF ON REINSTATEMENT
BEHAVIOR; AN INTRA-VTA INFUSION OF BDNF FAILED TO ALTER
REINSTATEMENT BEHAVIOR

Materials and Methods
All procedures used are identical to those described in detail in chapter 3. The
only difference was the stereotaxic coordinates used during the intra-cranial implantation
of cannula aimed at the VTA: (AlP=-5.2, M/L=1.2, DN=-8.0; at an angle of 8°).

Results
Histology
A schematic indicating the placement of the infusion cannulae tips of animals that
received bilateral BDNF or vehicle into the VT A (experiment 2) is shown in Fig. 1.
Subjects with cannulae tracts that did not meet the criteria of bilateral VT A placement are
not included in the schematic and the data from these animals was discarded.

109

-5.80

-6.04

-6.30

Figure AI. Schematic representing the cannula placement within the VT A.

Test I: Post-abstinence extinction Test.
The effect of a BDNF infusion into the VTA on extinction responding after 6 d of
abstinence was evaluated (Fig A2a). A two-way repeated measures mixed effects
ANOVA revealed a main effect of time (F1,21=15.39, P<O.Ol) but no effect of treatment
(FI ,21= I.64, P>0.05) or a treatment*time interaction(FI 21=1.23, P>0.05) on active lever

pressing between groups. There was no difference between groups on inactive lever
pressing during the extinction test (P>0.05). Rats in both treatment groups responded
significantly more on the active lever during the extinction test than during the last three
days of self-administration (P=0.008) demonstrating reinstatement of drug seeking.
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APPENDIX 2: EFFECTS OF INTRA-PFC BDNF INFUSION IN NAIVE RATS
ON BDNF PROTEIN EXPRESSION 24 HOURS FOLLOWING THE
INFUSION

Materials and Methods
NaIve rats underwent intracranial surgery as described in chapter 3. Intra-PFC
infusions of either BDNF (O.75f.lg/side;N=6) or vehicle (PBS; N=6) were given following
7 days of recovery from surgery.

BDNF protein expression was evaluated 24 hours

following the infusion from tissue dissected from the medial prefrontal cortex (mPFC),
NAc lateral caudate putamen (L CPu), medial caudate putamen (M CPu) basolateral
amygdale (BLA) and central amygdala (CeA). ELISA assays as described in chapter 3
were used to quantify changes in BDNF protein expression between groups.
70 -1

*

60 J

50

~

*

] 4° l
OJ)

Q.30

o Vehicle

1

-BDNF

20 '
10

o

--1--'- - - -

mPFC

NAc

LCPu

MCPu

BLA

CeA

Figure A3. BDNF Protein Expression 24 hours following an intra-PFC BDNF
infusions. 24 hours following an intra-PFC BDNF infusion there was a significant
increase in BDNF protein expression within the NAc BLA, and CeA (* p<O.005). No
significant difference in BDNF protein expression was observed in the mPFC L CPu or
MCPu.
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